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This master of science thesis introduces an implantable measurement device that
can be used to measure oxygen saturation (SpO2) with pulse oximetry methods.
The device is intended to be incorporated into a implantable measurement device
developed earlier at Tampere University of Technology (TUT). Two prototype de-
vices were built and tested externally on a human subject with number of different
measurement setups to determine how it would function in vivo.
Respiratory diseases are the cause of approximately 50 % of all mortality in
cattle. They can be hard to diagnose in early stages since there are no obvious
external symptoms, this can cause outbreaks in groups of cattle. SpO2 gives a good
measurement on how the respiratory system is functioning in the cattle by measuring
the amount of oxygenated hemoglobin versus deoxygenated hemoglobin.
The developed device measures the SpO2 with a probe made out of two light
emitting diodes (LED) and a photosensor. In the thesis two types of coating methods
where used to seal the probe, 3.5mm layer of medical grade epoxy and 15 µm layer
of Parylene-C. The effect of these coatings on the probe components and signals
where determined with measurements prior to coating and after. Parylene-C coating
had much less effect on the signal acquisition than the epoxy coating, where the
amplitude of the non-pulsatile signal increased on average over 1V and the pulsatile
part decreased in amplitude. For Parylene-C there was a minor decrease in the
amplitude of the non-pulsatile part but the pulsatile part had similar amplitude to
non-coated probe. This difference is partially explained with the fact that thicker
layer of coating creates internal scattering of light inside the coating. This light hits
the photosensor before being absorbed by tissue and thus increases the DC level.
A signal processing script was written in MATLAB to calculate the uncalibrated
SpO2 from the raw signal. The noise level in all measurements was estimated with
the standard deviation since the signal is unambigous and it was concluded that with
a moving average filter of 4- or 8-points it is possible to reduce the noise significantly.
Thermal radiation of the probe was estimated with test measurement of two
different LED drive currents and theoretical calculations, neither case showed any
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significant increase in temperature. The effect of fat tissue that will surround the
implant was also tested in a practical way with cow fat from a local supermarket.
According to theory, light penetrates well through fat tissue and this was confirmed
with measurements where the increased thickness of fat tissue decreased the ampli-
tude of the signal. By applying a 8-point moving average filter it was possible to
acquire a signal through ∼1cm thick layer of tissue with no perfusion. Number of
other minor topics were solved some theoretically and others practically.
The output of the thesis is a novel device that could be easily implanted in a
dairy-cow as well as other mammals. The thesis also presents new information on
the effects of coating SpO2 probes and the effects of fat tissue in cattle on the
SpO2 signal. Pulse oxygen saturation measurements have not been conducted with
an implantable meter before in any type of animal and thus certain uncertainty of
measurements can only be eliminated with an implantation of a real device.
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11. INTRODUCTION
Animal welfare has become a growing issue in the recent years. We can categorize
the role of the animals in our environment in a number of different ways such as
animals used for food production, animals used for toxicology studies, as pets and
for sports. With the growing number of earth population it is important that we
keep the animals healthy, thus maximizing their food production and reducing their
death ratio caused by lack of welfare.
This thesis aims to develop an oxygen saturation (SpO2) meter that can be eas-
ily integrated into the implantable measurement device monitoring well-being of
dairy-cattle. Current device developed prior to this thesis at Tampere University of
Technology (TUT) records temperature, single-channel electrocardiograph (ECG)
and activity of the animal with accelerometers [1]. The current device is built on
existing knowledge from number of previous implants that where mainly focused on
recording the ECG [2, 3].
The oxygen saturation meter will employ a technique called pulse oximetry that
is a standard non-invasive external monitoring method used in number of human
clinical applications as well as in some veterinarian applications [4]. The oxygen
saturation gives a good measure of how the respiratory system of the dairy-cow is
functioning. This can help in early detection of Bovine respiratory diseases (BRD)
that are a major health problem in cattle worldwide and the most common cause
of mortality in dairy-cattle [5]. The detection of Bovine respiratory diseases is very
hard at early stages but important since they can be easily transmitted between
cattle [6]. The method is a novel approach to that problem since first, there is no
kind of continuous measurement device existing for respiratory monitoring of dairy-
cattle. And second, there is no implantable oxygen saturation meter existing as a
commercial product and very little research exists about such a device.
1.1 Implantable oxygen saturation meter
The standard commercial pulse oximeter uses a pair of light emitting diodes (LED),
one red (wavelength (λ ≈ 660nm)) and one Infra-Red (IR) (λ ≈ 940nm). The diode
pair is located so that it emits light through a reasonable thin tissue which has good
perfusion underneath. A photodiode is placed opposite to the light emitters. The
absorption of the wavelengths differs, since oxygenated hemoglobin (HbO2) absorbs
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more IR light than red light and the deoxygenated hemoglobin (Hb) absorbs more
red light than IR light. The oxygen saturation can then be calculated by utilizing
the ratio of those two wavelengths, RED/IR, and comparing that value to calibrated
values or empirical tables [7].
The oxygen saturation meter presented in this thesis uses the reflection of the
light. Reflectance pulse oximetry has been initially described by Brinkman and Zi-
jlstra in 1949 [8] and later implemented by Zijlstra and Mook in 1962 [9]. Further
developments where made by A.Cohen and N.Wadsworth in 1972 [10]. Its main pur-
pose was to increase the ease of placing or acquiring oxygen saturation measurement
from subject since earlier meters where restricted to either through tissue, such as
finger or ear lobe, or reflection from the blood stream using intra venous fibre optic
catheter [11, 12]. With reflectance oxygen saturation measurement it is possible to
acquire signal from almost any place on the skin surface as long as there is some
perfusion.
In this thesis the reflectance oximeter is taken one step further by implanting
it under the skin of the dairy-cattle. This thesis will present the theory behind
measurements of SpO2 as as well as discussion on how most noise factors effecting
the external pulse oxygen saturation signal such as motion artifacts, ambient light,
skin pigmentation and skin thickness and hairs of cattle will effect the implantable
signal. Implantable pulse oximeters have not been tested clinically apart from a
pacemaker developed by Medtronics that used the principles of pulse oxygen satu-
ration measurement to measure the mixed venous oxygen saturation (SvO2) from
a lead placed in the right ventricular apex of a human subjects [13]. Two publica-
tions from 2008, one journal paper [14] and one conference paper [15], also propose
implantable oxygen saturation measurements for human measurements.
1.2 Problem statement
There are number of problems that have to be faced when developing a successful
implantable pulse oximeter, some of them can be solved before implantation but
some of them will only be concluded in vivo. This thesis works on a solution to
a number of problems, the main focus was set on problems that have little or no
publications such as the biocompatability of the probe that includes the LEDs and
the photosensor, due to tissue response electronic devices have to be sealed or coated
before implantation. Another biocompatability problem is how the implants thermal
radiation effects the tissue. There are very limited number of publications about this
topic, specially about the coating effect on the photosensor. Another problem faced
is the place of implantation and how different tissues effect the signal acquisition
specially fat tissue that will surround the implant.
The main focus of the thesis is still to design a prototype device that can mea-
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sure the SpO2 and can be incorporated in the well-being monitoring device. This
creates a number of problems by itself since the device has to be able to measure
ideally for months so the power consumption is an important factor, the device
also has to have few components since size is a real issue. It should be able to
adapt the brightness of the LEDs depending on the tissue surrounding it, since the
mammalian tissue is not uniform. Then there are number of problems regarding
the noise effecting the measurements and how it is possible to filter the signal to
enhance the quality. Grosenbough et al. concluded that SpO2 meters designed for
human measurements and that utilize signal processing algorithms designed for hu-
man SpO2 signals, should be compatible to cattle monitoring [16] and thus we base
our technology on human meter design.
All of these topics mentioned will be discussed in the thesis and a full practical
solution presented to some of them. Other topics are reasoned and a partially solved
which gives space for future improvements of the device.
42. BACKGROUND
This chapter reviews the basic principals needed to conduct SpO2 measurements
in all relevant applications. The aim of this chapter is to give the reader a broad
understanding of the different topics this thesis covers.
The structure of this background chapter is the following: Section 2.1 gives a
brief theoretical background on the physical properties of oxygen saturation mea-
surements, it covers the skin and tissue properties as well as theoretical measurement
principals. Section 2.2 makes a brief history review of oximeters both for human
and animal measurements as well as implantable meters. Section 2.3 discusses the
noise factors affecting external SpO2 measurements as well as expected noise in
implantable SpO2 measurements. Section 2.4 discusses the purpose of measuring
oxygen saturation in dairy-cattle as well as different issues with measuring oxygen
saturation in vivo and externally in dairy-cattle. Then there are sections that give
background information on some of the challenging technological issues that are
faced in this thesis. Those are coating materials of the implant in Section 2.5, signal
processing methods for the SpO2 signal, in Section 2.6 and power consumption of
the implantable meter in Section 2.7.
2.1 Theory of oxygen saturation measurements
The mammalian body does not function without oxygen. Oxygen delivery to cells
is a combined process of the respiratory system and the circulatory system. In this
process the respiratory system takes care of the ventilation and gas exchange that
occurs in the lungs. In the lungs oxygen is diffused into the blood in exchange of
carbon dioxide that is created as a by-product from the mitochondria, also known
as cellular respiration [17]. Ventilation is the process of moving air in and out of
the lungs. It has both involuntary components and voluntary components. The
involuntary control is controlled by the respiratory centers in the medulla oblongata
and pons that excite motor neurons that cause movement of respiratory muscles.
The motor neurons are generally controlled by this involuntary respiratory reflex but
it can also be controlled voluntary through commands delivered by the corticospinal
pathway [17]. The gas exchange that occurs in the lungs is driven by diffusion.
Diffusion is defined as the distribution process of atoms or molecules from an area of
higher concentration to an area of lower concentration [17]. The diffusion takes place
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Figure 2.1: Alveoli structure shown as multiple beads and in detail how the gas
exchange occurs in a single alveoli. Figure is adapted from [18, 19].
in the alveoli of the lungs which are small beds in the end of the bronchi structure
of the lungs surrounded by a capillary network, see Figure 2.1 for clarification.
The blood of the mammalian body is composed mostly of water and thus gas is
not particularly soluble. As an example, for every 100 mL of blood that leaves the
alveolar capillaries roughly 20 mL is oxygen. Of that amount only about 0.3 mL are
oxygen molecules in the solution [17]. The rest of the oxygen is bound to hemoglobin
(Hb) molecules that account for more then 95 percent of the intracellular protein
structure of red blood cells. The structure of a single hemoglobin is complex but can
be described with consisting of four heme units and four globin units. Heme being a
non-protein pigment that contains iron and is able to interact with oxygen molecules
and then globin being a polypetide chain. Each heme and globin unit can carry
one molecule of oxygen forming oxyhemoglobin (HbO2). Furthermore hemoglobin
molecule whose iron is unbound is called deoxyhemoglobin (Hb). Figure 2.2 shows
a simplified structure of hemoglobin where the heme and globin units are simply
shown as a uniform medium able to bind to four oxygen molecules. One red blood
cell contains about 280 million Hb molecules, meaning that each red blood cell can
carry over a billion oxygen molecules [17, 20].
Pulse oximetry measures only the group known as functional hemoglobins which is
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Figure 2.2: Simplified figure of oxygenated and deoxygenated hemoglobin as part of
a red blood cell. Adapted from [20].
the hemoglobin that is able to bind reversibly with molecular oxygen. Dysfunctional
hemoglobins are hemoglobins that are either not able to bind reversibly to oxygen
or they distrupt the normal function of oxyhemoglobins. The four most common
dysfunctional hemoglobins are methemoglobin (Hi), carboxyhemoglobin (HbCO),
sulfhemoglobin and carboxysulfurhemoglobin [21].
Deoxygenated Hb molecule is dark red while HbO2 is bright red. This color
change enables measuring the hemoglobin oxygen saturation with pulse oximetry
by utilizing a releationship between the absorption of red and IR light in the blood
[20].
Beer’s law also known as Beer-Lambert’s law presented in equation (2.1) describes
absorption of a single wavelength through a uniform tissue as a measure of intensity
of light [21].
I = I0e
−ε(λ)cd (2.1)
In the equation (2.1), I is the transmitted light, I0 is the incident light, ε(λ)
is the extinction coefficient or the absorptivity at a given wavelength of the ab-
sorbing substance (measured in L · mmol−1 · cm−1), c is the concentration of the
substance and d is the optical path length through the medium. Beer’s law does
not account for reflection of light at the surface or scattering inside the medium nor
any photochemical reactions or reaction between absorbent and solvent.
From Beer’s law it is possible to define the transmittance T of a light travelling
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through a medium, see equation (2.2) and the unscattered absorbance (A) of that
process, see equation (2.3) [21].
T =
I
I0
= e−ε(λ)cd (2.2)
A = −ln(T ) = ε(λ)cd (2.3)
Then expanding the unscattered absorbance quantity to count for more then one
substance in the medium by superposition of the individual absorbing processes.
This is defined as total absorbance (At).
At = ε1(λ)c1d1 + ε2(λ)c2d2 + ...+ εn(λ)cndn =
n∑
i=1
εi(λ)cidi (2.4)
Where εi(λ) and ci represent the extinction coefficient and concentration of the
substance i, di represents the optical path through that substance. It may differ
from substance to substance in the medium.
We apply this principle to the blood, making the assumption that majority of
the hemoglobin is Hb and HbO2 and that the optical path length is the same for
Hb and HbO2 see equation (2.5) [21].
At = [εHbO2(λ)cHbO2 + εHb(λ)cHb]d (2.5)
Where εHbO2(λ) and εHb(λ) are the extinction coefficients , cHbO2 and cHb the
concentrations and d the optical path length for Hb and HbO2. Zijlstra et al. mea-
sured the extinction coefficient of Hb and HbO2, for the wavelength from 450nm to
1000nm in humans, Table 2.1 shows the extinction coefficients for the wavelengths
660nm and 880nm that are the wavelengths of the LEDs used in our device [22].
The choice of the wavelengths will be justified in Section 3.2. The extinction coef-
ficients can be visualized as a function of wavelength as shown in Figure 2.3, the
isobestic point marked on the figure represents the point where εHbO2(λ) and εHb(λ)
are equal [23].
Table 2.1: Extinction coefficients for Hb and HbO2 for the specific wavelengths
660nm and 880nm [22].
λ εHb(λ) εHbO2(λ)
660 0.81 0.08
880 0.20 0.29
The functional arterial oxygen saturation can be shown as functional hemoglobin
saturation. It is common to ignore the effect of dysfunctional hemoglobins since
their amount is only around 2 % of the total amount of hemoglobins [16]. It is
2. BACKGROUND 8
600 700 800 900 1000
10
1
0.1
660 nm
Isobestic
point (805 nm)E
xti
nct
ion
coe
ffic
ien
t [ϵ
]
0.01
880 nm
Hb
HbO2
Wavelength [nm]
Figure 2.3: Extinction coefficients of Hb and HbO2 at wavelengths from 600nm to
1000nm with wavelengths 660nm and 880nm highlighted. Figure is adapted from [7].
possible to include the effect of dysfunctional hemoglobins with meters that utilize
multiple wavelengths and then we refer to fractional oxygen saturation. In this
thesis the term oxygen saturation (SpO2) is used when referring to the functional
arterial oxygen saturation as measured by the pulse oximeter defined with equation
2.6 [24, 21].
SpO2 =
HbO2
Hb+HbO2
· 100% = cHbO2
cHbO2 + cHb
· 100% (2.6)
The oxygen saturation of arterial blood is usually around 95-98% where the oxy-
gen saturation of venous blood is usually 60-80% [25]. The oxygen saturation in
venous blood is referred to as mixed venous oxygen saturation (SvO2). It gives a
measure of the saturation in pulmonary arteries after venous eﬄuents have been
mixed and they return to the left ventricle. The biggest difference between SpO2
and SvO2 is the pulsation of SpO2, as well as the factor that SvO2 represents the
amount of oxygen that can be utilized in periods of increased demands. There is an
interesting relationship between SpO2 and partial pressure of oxygen (PO2) in blood
as seen in Figure 2.4. The curve like shape of the figure is caused by increased affin-
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Figure 2.4: Oxygen saturation of hemoglobin in human blood as a function of
partial pressure of oxygen. Determined under normal conditions, with pH of 7.4 and
tempereature of 37oC. Figure is created from data presented in [17].
ity of hemoglobin towards oxygen as it binds to more and more molecules. PO2 in
air is roughly 20.9 % of the gases in atmosphere which is approximately 159 mmHg
[17].
Normal alveolar pressure is considered PO2 ≈ 100 mmHg, which gives a hemoglobin
saturation level of 97.5 %. Complete saturation occurs at the high level of PO2 ≈
250 mmHg. Difference in PO2 thus affects venous blood much more than arterial.
Inactive tissue has PO2 ≈ 40 mmHg, that is about 75 % of maximum saturation.
This means that tissue of a resting individual uses around 25% of available oxygen,
leaving the rest as a reserve. It is obvious from Figure 2.4 that small changes in
venous blood and thus lower level of PO2 induce large changes in the oxygen satura-
tion, indicating any respiratory problems that reduce the oxygen saturation and the
PO2. The regulation mechanism of the body for oxygen transport in arterial and
venous blood is quite complex and is out of the scope of this thesis, but it should
be noted that temperature and pH value of the blood as well as age of the mammal
affects the saturation-pressure curve [17].
A device called CO-oximeter measures the absorption with multiple wavelengths,
to measure the part of dysfunctional hemoglobins in arterial oxygen saturation. This
measurement is called arterial oxygen saturation (SaO2) and is sometimes referred
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to as the "gold standard" of the reference measurement for SpO2 since it is slightly
more accurate [24]. This measurement can also be performed with a blood gas
analyser.
2.1.1 Skin and tissue properties
The properties of skin and tissue play an important role in the measurement of
oxygen saturation since different layers of tissue have different amount of perfusion
that directly affects the SpO2 signal that is aquired. Equation (2.2) shows the
transmittance of light through a non-turbid sample according to Beer-Lambert law,
it can be represented in a different way as shown by equation (2.7).
T = e−µad (2.7)
Where µa is known as the absorption coefficient. According to Vogel and Venu-
gopalan [26] it is typical in the biomedical optics community to use the µa when ex-
pressing optical absorption properties in tissue and ε(λ) when expressing the optical
absorption properties for a specific isolated biomolecule. The absorption properties
of tissue for wavelengths in the visible spectra (400-780nm) are dominated by Hb,
HbO2 and Melanin that is the cause for skin pigmentation. Figure 2.5 shows the
absorption coefficient as a function of wavelength from 0.1µm to 12µm. As shown
in Figure 2.5, Hb has its highest absorption peak around λ = 433nm and HbO2
around 414nm which is in the violet region. Then other peaks for HbO2 are around
λ = 542nm and 576nm and for Hb around λ = 556nm that is in the green region
[26]. The reason why SpO2 measurements are usually conducted with wavelengths
in the red and IR region is that all biomolecules have very little absorption there,
thus Hb and HbO2 contribute significantly.
When scattering is absent or negligible such as in Beer-Lamberts law then it
is possible to define a quantity of penetration depth (δ) as the reciprocal of the
absorption coefficient as shown in equation (2.8).
δ =
1
µa
(2.8)
The penetration depth is defined as the point where the transmitted light is
reduced to 37 % of the incident light. This quantity is usually smaller at wavelengths
that are sensitive to scattering such as visible and near IR wavelengths (λ ≈ 400nm-
1200nm) [27].
Between 600nm - 1200nm there is a lack of strongly absorbing tissue chromphores.
According to Welch and van Gemert collimated light in this wavelength region can
penetrate several millimetres in tissue and the associated scattered light several
centimetres [28]. Kim and Wilson list the fundamental optical properties for ex vivo
2. BACKGROUND 11
Protein
Melanin
Hb
HbO
Water
Collagen
2Ab
so
rp
tio
n c
oe
ffic
ien
t [c
m^
-1]
Wavelength λ (μm)
0.1 0.3 1 3 10
10
10
10
10
10
10
10
6
5
4
3
2
1
0
Figure 2.5: The figure shows absorption coefficient (µa) of the principal tissue
chromophores as a function of wavelength from 0.1 µm to 12µm. The figure is
adapted from [26].
and in vivo tissue measurements as µa, scattering coefficient (µs), total attenuation
coefficient (µt = µa + µs), scattering phase function (p(cosθ), scattering anisotropy
(g), reduced scattering coefficient (µ′s = µs(1 − g)) and the tissue refractive index
(n) [29]. In this thesis we limit the theory to the absorption coefficient and consider
other parameters to be out of our scope.
2.1.2 Photoplethysmograph
The transmitted light is absorbed by different absorbing substances inside the bio-
logical tissue. The key substances are skin pigmentation, bones as well as arterial
and venous blood [21]. The pulse oximeter utilizes so called arterial pulsation that
can be explained with Figure 2.6, which shows how the transmitted light is ab-
sorbed by different tissues creating a non pulsatile part noted as DC and pulsatile
part noted as AC part of the signal. In the cardiac cycle the arteries contain more
blood in systole than in diastole, this directly influences the diameter of the veins
[21]. In systole the diameter of the veins increases and larger quantity of hemoglobin
increases the absorbance, on Figure 2.6 this relates to point L meaning the intensity
of the light that passes through the tissue is low. In diastole the point is marked
as H for the high intensity of light that passes through the tissue. This pulsating
signal is called Photoplethysmograph (PPG) [30].
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Figure 2.6: Photoplethysmograph signal showed in an intuitive way. Incident light
representing all light coming from the LEDs and striking the surface. Transmitted
light being the light sensed by the photosensor that is not absorbed by tissue. Figure
is adapted from [21].
We can apply Beer’s law to the transmitted light for systolic and diastolic part
of the signal. When the intensity is at its maximum the arteries have a thickness of
dmin and thickness of dmax when the intensity is the lowest, see equation (2.9) and
equation (2.10) below:
IH = I0 exp[−εDCcDCdDC ] exp[−[εHb(λ)cHb + εHbO2(λ)cHbO2 ]dmin] (2.9)
IL = I0 exp[−εDCcDCdDC ] exp[−[εHb(λ)cHb + εHbO2(λ)cHbO2 ]dmax] (2.10)
To eliminate the DC part of the signal the equation can be simplified by taking
the ratio of the two intensities and then we can make simplification on the equation
by substituting ∆d for the variation in thickness dmax − dmin see equation (2.11).:
IH
IL
=
I0 exp[−εDCcDCdDC ] exp[−[εHb(λ)cHb + εHbO2(λ)cHbO2 ]dmin]
I0 exp[−εDCcDCdDC ] exp[−[εHb(λ)cHb + εHbO2(λ)cHbO2 ]dmax]
= exp[(εHb(λ)cHb + εHbO2(λ)cHb02)∆d]
(2.11)
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The unscattered absorbance or in more detail the relative absorbance of the blood
can be defined from equation (2.11) in a similar way as in equation (2.3):
ln
(
IH
IL
)
= +(εHb(λ)cHb + εHbO2(λ)cHbO2)∆d (2.12)
Sarpeshkar [31] states that it is possible to make the assumption that the mod-
ulated signal output from the receiving photoreceptor, iac is much smaller then
the absolute level IDC . Further stating that this is a good assumption in practice
where the modulation depth in pulse oximetry noted as Arlt−bld ≈ iac/IDC is usually
0.5− 2.0%.
Equation (2.12) then can be further simplified as:
ln
(
IDC +
iac
2
IDC − iac2
)
= (εHb(λ)cHb + εHbO2(λ)cHbO2)∆d
Arlt−bld ≈ iac
IDC
= (εHb(λ)cHb + εHbO2(λ)cHbO2)∆d
(2.13)
In the final step we must realize that relative absorbance of the blood will differ
between the red and infrared wavelengths. That is the fundamental point in pulse
oximetry measurements, that is if we define the ratio (R) of relative absorbance
between the wavelengths. Then these absorbances only depend on the light absorbed
in the arterial blood, since the optical path lengths for the red LED and the IR LED
can be considered equal:
R =
ln(iH,R/iL,R)
ln(iH,IR/iL,IR)
≈ (i
R
ac/I
R
DC)
iIRac /I
IR
DC)
=
(εHb(λR)cHb + εHbO2(λR)cHbO2)∆dR
(εHb(λIR)cHb + εHbO2(λIR)cHbO2)∆dIR
=
(εHb(λR)cHb + εHbO2(λR)cHbO2)
(εHb(λIR)cHb + εHbO2(λIR)cHbO2)
(2.14)
With some simple algebraic manipulation and the relationship introduced in equa-
tion (2.6) we can show the SpO2 as function of R [21]:
SpO2 =
εHb(λR)− εHb(λIR)R
εHb(λR)− εHbO2(λR) + [εHbO2(λIR)− εHb(λIR)]R
· 100% (2.15)
Using the extinction coefficients from Table 2.1 the relationship becomes:
SpO2 =
0.81− 0.20R
0.73 + 0.09R
(2.16)
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Figure 2.7: Theoretical curve showing Beer-Lamberts law created from equation
(2.16) and empirical curve as suggested by Sarpeshkar [31], created from equation
(2.17).
Sarpeshkar mentions in [31] that since Beer’s law does not account for reflection
of light at the surface of skin or the scattering of light inside human tissue, the ratio
R can be approximated with equation (2.17).
SpO2 = 110− 25R (2.17)
Figure 2.7 shows graphical interpretation of equation (2.16) and equation (2.17).
2.1.3 Reflectance pulse oximetry
Reflectance pulse oximetry as the name implies measures the reflected light that is
scattered back from the tissue. Figure 2.8 shows the difference of through finger and
reflectance oximetry probes as presented by Webster [21]. The figure is a simplified
version of the process as it does not show any scattering that occurs from the tissue
itself but only light that is scattered back from bone. A more accurate representation
of a reflectance measurement setup is shown in Figure 2.9. Both through tissue and
reflectance meters utilize the same theoretical principles but as Figure 2.8 and 2.9
suggests, differ slightly in probe structure and calibration.
As mentioned earlier Beer-Lambert law (presented earlier with equation (2.1)),
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Figure 2.8: The figure shows two pulse oximeters, the one on left side measures
the absorption through finger and the one on right measures the scattering from the
tissue. Figure is adapted from [21]
R IR R IR
Light scattering Light scattering
Light sources Light sources Chip Light detector
Light detector
Clip
Figure 2.9: The figure shows two meters just as Figure 2.8. The one on the left
measures absorption thorough finger and the one on right measures the scattering
from tissue. The figure is adapted from [32]
does not account for any scattering inside the tissue, which is not true with whole
blood [21]. Scattering occurs from objects that are similar in size as the wavelength
used and red blood cells are approximately 700nm in diameter. In humans the
cells also play a role since they have a diameter of 10 µm to 30 µm and many
of their internal parts are in the range of 50 nm - 1000 nm, such as ribosomes,
lysosomes, mitochondrion and the nucleus [17]. Yet another factor contributing
to the scattering is a discontinuity in index of refraction between plasma and red
blood cells. Thus light scatters multiple times inside the tissue and this increases
the optical path length and thus the absorbance [33]. Steinke and Shepart showed
that the relationship between oxygen saturation and the total scattering effects is
approximately linear so that the accuracy of the oximeter should not be affected in a
negative way [33, 21]. Marjoron and Nelson [34], presented data combined from few
publications where the absorption coefficient for whole blood is presented at 100%
(arterial) and 70% (venous) oxygen saturation, Table 2.2 shows this data. The table
shows clearly how the penetration depth of red wavelength (λ = 600nm) is affected
in a more negative way by venous blood then IR wavelength (λ = 1064).
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Table 2.2: The table shows the absorption coefficient (µa) and the penetration depth
(δ) for two wavelengths λ=600nm and λ = 1064nm, at two saturation percentages
namely 100% SpO2 and at 70% SpO2 [34].
Absorption Coefficient µa (mm−1) Penetration depth δ (mm)
λ (nm) SpO2 (100%) SpO2 (70%) SpO2 (100%) SpO2 (70%)
600 2.5 4.0 0.4 0.025
1064 0.5 0.22 2 4.55
Number of theoretical methods exist that describe optical properties of tissue as
multiple layers with respect to light propagation, absorption and scattering. Such
methods include analytics using Maxwell’s equations and Monte Carlo simulations
[32]. Some of the more commonly known theories are transport theory, Twersky’s
multiple scattering theory and Kubelka-Munk theory [21, 28]. Such theories and
modelling are considered out of the scope of this thesis due to complexity and their
failure to replace the empirical calibration curves for SpO2 meters.
There are multiple interesting parameters regarding the design of reflectance pulse
oximeter. Mendelson and Ochs [35] studied number of them such as spacing between
LEDs and photodetector, effect of skin temperature and effect of hypoxemia. They
discovered a possibility to increase the signal-to-noise ratio (SNR) with certain trait-
off consisting of increasing distance between LEDs and the photodetector to acquire
larger plethysmographs with the cost of higher LED driving current. Their tests
where done on separation distances of 4-11 mm. For constant LED intensity, the
detected light decreases exponentially with increasing distance [35].
2.2 History of pulse oxygen saturation meters
The first commercial oximeter that can be compared to the commercial pulse oxime-
ters, was the Hewlett-Packard ear oximeter in 1970. It used a fiber optic light guide
that transmitted eight different wavelength. The arterial oxygen saturation was then
calculated from these eight wavelengths. The Hewlett-Packard ear oximeter utilized
the Beer-Lambert law published in 1851 by August Beer as an expansion of a princi-
ple theory between the absorption of light and the amount of absorbent described by
Johann Heinrich Lambert and published 1760 [36]. Takuo Aoyagi influenced greatly
the transition from the Hewlett-Packard oximeter to the general commercial pulse
oximeter as we know it today. First in 1971 he acknowledged the pulsatile arterial
part of the PPG and used it to separate the absorption due to arteries from other
tissues. And later in 1974 he developed a prototype pulse oximeter that divided the
energy received into two filters centered at 650nm and 805nm the isobestic point for
hemoglobin as seen in Figure 2.3. Aoyagis meter was far from perfect but it laid
the foundations for the first commercially available pulse oximeter in the year 1975
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[36]. As mentioned previously in Section 1.1, reflectance pulse oximetry was first
described by Brinkman and Zijlstra in 1949 [8] and later implementations by Zijlstra
and Mook in 1962 [9] provided the first commercial device that utilized reflectance
pulse oximetry in the eighties.
2.2.1 Animal meters
Pulse oximetry has been used to some extend in animal measurements most common
being external measurements of rodents such as mice and rats where a number
of commercial products exist. Nellcor and Nonin the biggest producer of oxygen
saturation meters, both have their veterinarian line of meters for both rodents as well
as domesticated animals such as horses, cats and dogs [37, 38]. Another company
SurgiVet specializes in only veterinarian meters and has a big catalog of products,
both oximeters and probes [39]. Grosenbaugh et al. studied the absorbance spectra
over the wavelength of 600nm to 1000nm, for different animals (dog, cat, horse,
cow and pig) [16]. Their conclusion was that there where minor differences in the
absorbance of both HbO2 and Hb between human and different animals. However
they make the statement that corrections for the presence of Hi, light scattering by
impurities in the solution and technical error renderes these differences statistically
insignificant. Thus pulse oximeters that are designed for human measurements and
utilize signal processing algorithms designed for human PPG signals, should be
compatible with the animal species they studied [16].
Starr Life Sciences Inc. introduced their first commercial meter for rodents
in 2006 and today has built up a complete series of external SpO2 meters called
MouseOXTM [40]. Starr Life states to this date on their company homepage that
they "manufactured the world’s first and only patented non-invasive vital signs mon-
itor specifically designed for small laboratory animals". The probes they offer are
all through tissue available for thigh, foot, throat and collar measurements. Their
meters have been used in total of 101 publications as of January 2011 in research
ranging from pulmonary, respiratory and cardiovascular to pharmacology and tox-
icology studies. Number of other meters exist today such as the MouseSTAT TM
from Kent Scientific [41] that offers unique through skin probes. Another meter is
the CANL-425SV-A from Med Associates Inc. that offers both standard through
skin probes as well as transreflectance sensors [42]. All the companies offer the clas-
sic Y shaped probe, Nellcor offering a miniaturized transreflectance probe as well
and SurgiVet offering a reflectance probe that can also be used rectally for cats and
dogs as well as a C-shaped probe specially good for the legs and tails of cats, dogs
and horses since it does not deflect the angle of the photosensor. Figure 2.10a-c
shows an example of Y- and C-shaped probes as well as a rectal probe.
Matthews et al. [44] made a comparison study published in 2003 using 5 different
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(a) V1711 (b) V1707 (c) V1700
Figure 2.10: List of probes manufactured by SurgiVet. Probe V1711 is an example
of a classic Y-shaped probe. Probe V1707 has a special C-shape that is considered
specially good for measurement on cats, dogs and horses. Since it can be fitted more
easily to wider diameter such as a tail or a leg without deflecting the angle of the
photosensor and LEDs too much . Probe V1700 is a transreflectance probe that can
also be used rectally for cats and dogs [43].
oximeters commercially available, both meters specially designed for human mea-
surements and meters designed for animal use. Four of them from Nellcor and one
from SurgiVet. The oximeters where tested on five animals of each species (dogs,
cats and horses). Five different measurement placements where used the tongue, toe,
ear, lip and the prepuce or vulva depending on the gender of the animal. The ani-
mals where anaesthetized and SpO2 was measured in parallel with a CO-oximeter.
In horses the root-mean-square difference (RMSD) for all the devices was between
±2 − 5% and the Nellcor devices had a failure rate from 0% to 21%. The tongue
and the ear produced the best signal. Big differences between meters where mostly
blamed on differences in probes as well as internal detection algorithms and filters
inside the measurements devices. For horses, pulse oximetry is considered a method
when standard arterial blood gas analysis is not available since it is affected by per-
fusion deficits, location of the device, pigmented skin, and type of transducer. It can
on the other hand have a great value as a rough assessment of respiratory function
and to assess response to therapy [45, 46].
Two papers published in 1999 and 2000 by Uysterpruyst and Coghe et al. [47],
[48], assessed pulse oximetry in cattle as well as the accuracy in newborn calves.
These papers will be further addressed in Chapter 2.4.
2.2.2 Implantable meters
Implantable pulse oximeter does not exist on the market for animals or human. The
closest thing to implantable pulse oximeter that has been developed and tested clin-
ically is a pacemaker developed in the 90’s by Medtronics Inc. model number 8007
that came with a special pacing lead numbered 4327A [13, 49]. The combination
used the principles of pulse oxygen saturation to measure the SvO2 from a lead that
was placed inside the right ventricular apex with standard implantation techniques.
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The oxygen sensor part was sealed inside a sapphire capsule (see Figure 2.11), 3cm
from the lead tip. The sensor has two LEDs (red (660nm) and IR (880nm)), a
photo-detector and an integrated circuit. A microprocessor inside the pacemakers
capsule samples the SvO2 data every 4s as the pacemaker synchronizes the sample
to the R-wave of the heart with a piezoelectric crystal that is mounted on the in-
side of the pacemaker. The pacemaker can pace with rate response using either the
piezoelectric crystal or the SvO2 detector. Both the activity and the SvO2 levels
can be accessed with real-time telemetry as well as storing the SvO2 values in the
pacemakers memory [13, 49].
Kjellström et al. published a paper in 2004 where they had done a six year fol-
low up on 9 patients implanted with the Medtronics model 8007 and 4327A combo
[50]. Their conclusion was that the oxygen saturation levels correlated well between
implantable sensor and SvO2 obtained with optical Swan-Ganz catheters or blood
samples. Kjellström also concluded that long-term stability determined with com-
parison of resting values and responses to sub-maximal exercise was reproducible
over the follow up period.
Figure 2.11: Medtronics Model 4327A
Oxygen sensing lead [51].
Figure 2.12: A implantable cuff probe
as proposed by Reichelt et al. [14].
A paper by Reichelt et al. from 2008 describes a development of implantable pulse
oximeter [14]. Their design proposes a meter to be used for long term surveillance
of patients in critical care. They list several clinical situations in which the meter
could be useful such as cardiac insufficiency and pulmonary hypertension for high-
risk cardiovascular patients, chronic hypoxemia, surveillance of premature infants as
well as surveillance and optimization of surgery timing for children with congenital
heart defects. It utilizes an optically transparent cuff that includes the LEDs as well
as a photosensor and is wrapped directly around an artery. Figure 2.12 shows the
proposed probe. In the proposed solution there is a certain trade-off between the
complexity of the surgery and the acquired AC signal straight from artery. They
made an experimental setup where blood was pumped through an extracted animal
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artery and their AC to DC ratio ranged from 20% to 40% compared to 1% to 10%
in normal through finger human oximetry and around 1% for standard reflectance
pulse oximetry [21]. The LEDs used an operating current of 20mA.
A conference paper also dated from 2008 describes an implantable telemetry
capsule that measures oxygen saturation with reflectance pulse oximetry [15]. The
purpose of the capsule is to measure fetal vital signs from the uterus of the mother
specially in and after surgery that might be needed on the fetus. The paper is mainly
a technical paper for a complete system of wireless transmitter, oxygen saturation
and a continuous power supply system. It does not discuss any problems that
can occur during measurements or the material used for sealing the implant. The
implant is tested by measuring a signal from a human finger inside a water tank.
Although non-implantable but certainly related are so called intrapartum oxy-
gen saturation meters used in labour for fetal SpO2 measurements. Studies dated
back to 1989 [52] introduce such a devise and continuous research in the 90’s in-
troduce a fully functional intrapartum reflectance pulse oximeter that uses a suc-
tion fixation [53]. This led to the first fetal oxygen saturation monitoring system
to be approved by the Food and Drug Administration (FDA) in 2000 [54] named
OxiF irstTMFetal Oxygen Saturation Monitoring System and was manufactured
by Mallinckrodt and Nellcor Perinatal Business.
2.3 Noise and errors in oximetry measurements
Webster [55] states three major sources of noise and errors in SpO2 measurements.
Motion artifacts, reduced saturation levels (<80%) and peripheral vasoconstriction
(low perfusion) that all can severely affect the PPG signal. Other sources of noise
and errors are probe placement, dyshemoglobins, ambient light, intravascular dyes,
nail polish and skin pigmentation. It is quite obvious that some of these sources do
not apply to implantable meters. Figure 2.13 shows an example of the most common
noise artifacts as presented by Jubran [56].
The most important noise source, specially for implantable meters and moving
subjects would be motion artifacts. Trivedi et al. [57] tested five different commer-
cial meters with motion generator at 2Hz and 4Hz where the subject hands where
moved 10cm to generate an artificial shivering. Their conclusion was that there is a
significant difference in commercial meters where the failure rates range from 5% to
50% depending on meters. What is interesting about their study is that the error
rate for detecting heart rate (HR) is much greater than for the detection of SpO2
that ranges from 2% to 10% in 2Hz vibration, this is evident from Figure 2.13c
and 2.13d since SpO2 utilizes the ratio of two PPG signals instead of a single PPG
signal, meaning the waveform is not as important. It’s possible to decrease motion
artifacts by avoiding all relative motion between sensor and the subject but this also
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(a) Normal Signal
(b) Low Perfusion
(c) Noise Artifact
(d) Motion Artifact
Figure 2.13: The most common type of noise sources affecting SpO2 measurements.
The figure is adapted from [56].
reveals a sensitive relationship between applied pressure of sensor and the received
signal. There also exists filtering methods that compensate for movement artifacts
that will be discussed in Section 2.6.
A study by Dassel et al. [58] showed that it is possible to increase the SNR by
applying pressure to reflectance oximeter placed on the forehead of a measurement
subject. The study proposes that applying pressure to the probe forces venous blood
out of the area under the probe reducing disturbing influences of non pulsitile venous
blood. Another effect of pressure to probe is the relationship between increase in
flow velocities that cause an increase in pulse size. One method in neonatal care to
use suction probe on the forehead of infants to record the SpO2. This also reduces
noise created with movements since it reduces the movement between the subject
and the meter used.
Several studies [59, 60, 61] have shown the relationship between peripheral vaso-
constriction and effect of SpO2. Kelleher et al. [59] were the first to describe this
effect. It is considered as a fact from these studies that oxygen saturation values
measured with pulse oximetry increase during hypothermia induced peripheral vaso-
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constriction and decreases during hyperthermia induced peripheral vasodilation. It
was thought that skin/limb temperature was the main trigger of this mechanism but
as Talke et al. [61] pointed out in 2006 this effect also happens when temperature is
kept constant and peripheral vasoconstrictors where administered to the subjects.
The mechanism for this change in perfusion remains speculative and unproven until
this day. It is still important to realize that adequate arterial pulsation is required
since a significant decrease in peripheral vasoconstriction such as in a shock or severe
hypotension might lead to very low SNR.
Since oximeters estimate the functional saturation but not the fractional satura-
tion, effects by abnormal haemoglobins, HbCO and other dyshemoglobins can affect
the measurement data as well as any substance that absorbs light in the same wave-
length as the LEDs of the probe. HbCO having the most effect since the oximeter
detects them as HbO2 and thus overestimates the concentration [62].
Ambient light coming from sources such as surgical lamps , infrared xenon lights
and fluorescent lamps has been studied greatly. With strong amount of light its
possible to saturate the light photosensor of the measurement device. Trivedi et
al. made a study how an ambient light in a clinical scenario effects the oximetry
measurements of five commercial devices. Their setup was to perform oximetry
measurement of a distance of ≈ 1.2m from a standard surgical lamp. The error in
SpO2 varied from 6% to 60%. Another more recent study by Fluck et al. states that
ambient light has no statistical significance [63]. They studied five different types
of lights but distance from the subject is unclear. Both studies utilized the same
probe the Nellcor N-200. Rusch et al. states that reflectance probes provide better
shielding to ambient light then probes that work through finger [64].
Other noise sources such as intravascular dyes, nail polish and skin pigmentation
are considered minor and unrelated for this thesis topic. It is good to keep in mind
that Dairy-Cattle move much less and slower than for example cats, dogs and horses
and that can help us estimate the effect of noise in the acquired signal.
Though currently being unpublished data we know from previous implants done
in the Remowel project that noise effecting the ECG comes mainly from movement
of the animal, see Figure 2.14a for accelerometer data and how it affects the ECG
data in Figure 2.14b. When the cow is still as the first 20 minutes indicate all
signals are very stable but as soon as the cow starts moving the noise increases in
correlation to the amount of movement. As seen in Figure 2.14c the HR of the cow
is around 75 beats-per-minute (bpm) when the cow is at rest and goes up to 100
bpm when the cow is active. Our unpublished data shows a range from 60 bpm to
120 bpm that can also be related to the size and age of the cow, this indicates a HR
extracted from a PPG signal would be around 1-2 Hz.
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Figure 2.14: The figure shows a 50min part of a signal recorded with previous im-
plants from the Remowel group. (a) shows data from the Y-axis of the accelerometer
inside the implant, it is sampled at 16Hz and gives good indication if the animal is
resting or if it is active. (b) shows the ECG data sampled at 341.3Hz for the exact
same period of time. (c) shows the HR calculated from the ECG signal where the
noise spikes have been averaged out.
2.4 Oxygen saturation meters in cattle monitoring
No commercial pulse oximeter exist specific for cattle monitoring, but as reviewed
earlier in Section 2.2.1 there are some meters on the market focused on large animal
2. BACKGROUND 24
measurements such as horses. Some studies have also been made with both external
pulse oximeters [47, 48] and near infrared spectroscopy [65] mostly to asses if the
instrumentation technique is useful for diagnosis. Coghe et al. [47] showed that pulse
oximeters placed on the shaved, non-pigmented tail of a cattle gives no significant
difference of measurements done with pulse oximetry SpO2 and with blood gas
analyser SaO2. In their study they measured 46 cattle where they where able to
get a clear signal from 38 by placing the probe on the fourth or fifth verebra of the
tail. Thickness of tail was considered the cause of the three non-signals and in five
cases the whole tail was darkly pigmented. They pointed out that earlier studies in
humans had shown that hair and pigmentation affects greatly the availability of a
good signal. It is considered a disadvantage that they don’t describe the oximeter
they used or the probes. However, it is evident from Figure 1 in their publication
that it’s a through tissue probe. The second paper the group released described
the pulse oximeter being a Nellcor N-3000 with Vet Sat Sensor that was covered
with black rubber to shield them from ambient light [48]. The Vet Sat Sensor has a
Y-shape as can be seen in Figure 2.15a-b.
(a) (b)
Figure 2.15: Nellcor Vet Sat Sensor probe (Figure 2.15a) shown in practice mea-
suring on the tongue of a dog (Figure 2.15b) [37]
Even though Coghe and Ustepruyst et al. confirmed the possibility of SpO2 mea-
surement in cattle, with a oxygen saturation meter designed for humans. We can
validate the case even further by comparing two properties of blood in human and
cattle. The weight of hemoglobin, is typically around 14 g Hb/100 mL in human
blood [20] while compared to that of dairy-cattle it is typically around 11 g Hb/100
mL blood [66]. Another characteristic is the absorbance spectra which Grosenbaugh
et al. [16] showed that difference between human and cattle is statistically insignif-
icant as stated earlier in Section 2.2.1. The coefficients they measured are shown in
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Table 2.3. They also measured the fractional amounts of both methemoglobin and
carboxyhemoglobin as shown in Table 2.4
Table 2.3: Extinction coefficients for Hb and HbO2 for the specific wavelengths
660nm and 940nm in humans and cattle as measured by Grosenbaugh et al. [16].
λ εHb(λ) εHb(λ) εHbO2(λ) εHbO2(λ)
Human Cattle Human Cattle
660 0.84 ± 0.2 0.89 ± 0.06 0.096 ± 0.01 0.12 ± 0.03
940 0.20 ± 0.01 0.25 ± 0.03 0.26 ± 0.01 0.29 ± 0.03
Table 2.4: Fractional amount of Hi and HbCO in the hemoglobin solution subject
to spectral analysis as published by Grosenbaugh et al. [16].
Species Hi(%) HbCO(%)
Human 0.67 ± 0.1 1.0 ± 0.5
Cattle 0.68 ± 0.1 1.2 ± 0.1
2.4.1 Diagnostic purpose
There are multiple respiratory problems that can effect dairy-cattle, Divers and Peek
et al. [67] made an extensive book covering all diseases that affect dairy cattle. They
list eight groups of respiratory diseases:
1. Mechanical or Obstructive Diseases
2. Inflammatory Diseases
3. Bacterial Bronchopneumonia
4. Diseases of the lower airway
5. Viral Diseases of Respiratory Tract
6. Parasitic Pneumonia
7. Noninfectious Causes of Acute Respiratory Distress in Cattle
8. Other less common causes of Respiratory Distress
Even though all of those diseases can be indicated with pulse oximetry, we are
specially interested in types 3 to 8 which are all categorized as diseases of the lower
airway. Those types of diseases can be hard to diagnose in early stage, causing a
spread among the cattle. The most notorious of these diseases are number of viruses
and bacteria that induce bovine respiratory diseases (BRD).
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The impact of respiratory diseases can be categorized as mortality (death loss) or
morbidity (sickness). Smith published a paper in 1998 where he states that cost of
morbidity can be even higher than mortality due to expenses related to medication,
labour of treatment, premature culling and reduced performance during and after
the illness. Smith collected studies of mortality and morbidity in feedlot cattle where
morbidity due to respiratory diseases was estimated to be 72% of total disorders and
mortality due to respiratory diseases around 47.4 % [68]. The economical impact of
BRD has not been studied greatly but Griffin published a study in 1997 where he
estimated that cost in the USA of $ 750 millions annually for farmers with indirect
cost of treatments and prevention to be even close to $ 3 billion [69]. National Animal
Disease Information Service (NADIS) in the UK, publishes data that respiratory
diseases in feedlot- and dairy-cattle account for about £60 million annually [70].
The specific causes and symptoms of those viral and bacterial pathogens is out
of the scope of this thesis but a study from 2004 indicates that in Finland parain-
fluenza virus-3 (PIV-3), bovine respiratory syncytial virus (BRSV), bovine coron-
avirus (BCV), bovine adenovirus-3 (BAV-3) and bovine adenovirus-7 (BAV-7) are
the most common [71]. Of the different BRD viral and bacterial pathogens, BRSV
has in the last 20 years become one of the most important respiratory pathogen in
dairy cattle as it invades the cell lining of the trachea and lungs and is commonly
found in BRD cases. It shows high morbidity in several days to one week after
infection, signs of infection include increased temperature as high as 40C to 42.22C,
depression, anorexia, decreased milk production, salivation as well as increased res-
piratory rate from forty to hundred breaths per. min. Each cow has to be diagnosed
by a specialist to determine infection. The drug treatment to BRSV can include
broad-spectrum antibiotics, non steroidal anti inflammatory drugs (NSAID), corti-
costeroids, antihistamine, atropine, furosemide and dexamethasone [67]. Intranasal
oxygen also helps with decreasing the respiratory rate. The cost of each treatment
of BRD was estimated $ 15.57 according to Faber et al. in 1999 [72]. Schneider et
al. included indirect costs in feedlot cattle such as reduction of average daily gains
(ADG) and less carcass value due to quality grade to amplify the cost to $ 15.76, $
22.09 or $ 46.70 depending on number of treatments given [73].
When writing this thesis the pharmaceutical giant Merck announced a new an-
tibiotic drug for some BRD pathogens, this shows the constant work that is being
done on fighting BRD. This also shows that implantable pulse oximeter could be
used for clinical drug trials in a obvious active market [74].
2.4.2 Placement of meter in tissue
The placement of the implantable meter is an important factor for a successful
measurement. External measurements have been conducted on cattle from various
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places such as the ear, the scrotum, the tongue, the tail, the nasal septum and the
lip of the vulva. With external meters the cattle shows signs of stress when meters
were placed on the ear, tongue or nasal septum inducing too much noise for a stable
reading [47]. Coghe et al. paper still showed that pulse oximetry measurements can
be conducted anywhere on the cattle where there is a possibility to shine through
skin. No studies measuring the oxygen saturation in cattle with a transreflectance
meter have been published according to the author of this thesis, those kind of
measurements should be conducted prior to implantation at least on the tail of the
cattle.
As stated earlier in Section 2.1.3, backscatter is an important factor when deciding
the placement of the meter since it enhances the acquired signal. Placement near
the ribs of the cattle could be sufficient for a nice backscatter and stronger PPG
signal. The lower part of the rib is the widest according to Figure 2.16 that shows a
suggested placement of implant. This is a very similar placement as has been used
in earlier implants of the Remowel group, for recordings of ECG, temperature and
activity of the cattle [1].
Implant
Figure 2.16: The figure shows the skeleton of a cow drawn by Fred V. Theobald
[75]
Unpublished knowledge from those implantations gives information that consider-
able amount of fat tissue exist in those areas. Another thing that should be studied
prior to implant, is how much the fat tissue degrades the PPG signal since very
limited amount of studies have been performed on mammalian fat. One study by
Veen et al. used clear purified oil obtained from pig lard, their result was presented
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in a conference paper [76] and their data is freely available online and was used to
create Figure 2.17, the processing steps of the oil are also explained online in detail
[77].
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Figure 2.17: The figure shows the absorption coefficient for purified oil obtained
from pig lard as a function of wavelength. The figure is constructed from data avail-
able at [77].
When measuring the PPG signal with reflectance pulse oximetry it is usually the
movement of the bone relative to the meter that causes motion artifacts as well as
skin to meter movements. It is important that the backscattered light of the red and
IR LEDs does not change significantly when conducting measurements. If meter is
placed near the ribs there is a possibility that some motion artifacts due to breathing
occur though it is not evident from the acceleration data shown in Figure 2.14c.
Since the PPG signal can also be measured from the internally scattered light
such as shown in Figure 2.9 the perfusion of the tissue near the meter is important.
Figure 2.18 shows how the perfusion in the layers of the skin is represented with
black dots. The perfusion is very high where the epidermis and dermis meet, this is
because the skin is used for thermal regulation and thus has higher perfusion then
other tissue [78]. A more interesting figure is Figure 2.19 that shows a histological
section of a pig skin, it is quite clear from that figure that small vessels have good
perfusion once you have penetrated the dermis layer. These figures indicate that
there is possibility of receiving a low perfusion signal if LEDs are directed towards
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the ribs. But they also indicate that there might be a possibility to receive the PPG
signal from LEDs shining towards the skin rather then towards the ribs. This can
only be concluded with in vivo measurements.
Stratium 
corneum
Papillary 
Layer
Vessel
VesselReticular Layer
Epidermis
Dermis
Figure 2.18: The figure shows the layers of tissue in a human shoulder, the black
dots indicate perfusion of the tissue. Figure is adapted from [27].
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Figure 2.19: The figure shows a histological section of pig skin. Figure is adapted
from [27].
2.5 Coating materials
As stated earlier the device has to be coated or sealed to fulfil its biocompatible
requirements set by the FDA [79]. Biocompatability is according to definition "The
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property of being biologically compatible by not producing a toxic, injurious, or
immunological response in living tissue" [80]. Previous implants in the Remowel
project have had a hybrid type of coating, consisting of both Parylene-C and medical
grade epoxy [1]. In those implants the whole device apart from the electrodes was
sealed with good result. Thus one of the main interest in the thesis is to determine
what kind of effect biocompatible encapsulation has on the LEDs and photosensor.
He et al. published a paper where a 20 µm layer of Parylene-C was deposited on
top of Silicon coated LED of white and red light (λ = 630nm), their result showed
that the optical transmittance was more than 95 % of the non coated LED. Example
result is 10,4 lm without the coating compared to 10,2 lm where the red LED was
coated. They also tested the coated LED in a 1000 hour test where the LED was
placed in temperature of 85 ◦C and humidity of 85 %. It showed no signs of ware
compared to the uncoated LED that showed abnormal black residues around the
lead as well as silver thermal adhesive after mechanical decapsulation [81].
The biocompatible epoxy that has been used before in Remowel project is EPO-
TEK 301-2FL from Epoxy Technology. It is according to the datasheet suitable
for LED encapsulation where it has an optical transmittance of over 99 % in the
spectral transmission range of 400-1000 nm [82]. There where no studies found on
the optimal coating thickness for photodiodes and LEDs or how the thickness of
epoxy will effect the reflectance.
The third method possible for coating the LEDs is described in paper currently In
Press by Lee et al., it uses biocompatible polytetrafluoroethylene (PTFE) also known
as Teflon to coat a Gan-LED. The paper is mostly describing a complete device and
does not describe in detail the coating process [83]. This is an alternative that could
be researched but is considered out of the scope of this thesis since the author has
experience with the other two processes and non with biocompatible teflon.
Another issue regarding biocompatability is the temperature effect the implant
has, for external SpO2 meters the FDA says that "the device should not present a
risk due to excessive surface temperature of the applied part" [84] and that further
info is given in clause 42 of ISO9919 standard.
2.6 Signal processing of oxygen saturation signals
When discussing signal processing for oxygen saturation signals there are multiple
aspects to consider, such as filtering of the signal in analog and digital domain,
SpO2 calculation, volume of individual blood pulsations supplying the tissue and
extraction of other parameters such as the HR and blood pressure [55, 30]. De-
pending on weather you want to calculate the SpO2 or SvO2, the DC part of the
signal is relevant. In this thesis we are only going to review briefly methods for
filtering and SpO2 calculations that could be done in real-time on the device and
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more importantly justify their use, other processing is considered out of the scope
of this thesis. Since the device is a prototype meant for measurements that have not
been published before it is hard to make any definite statements on how we could
process the signal even further.
2.6.1 Analog to digital conversion
Analog to Digital Conversion of the signal is done through an analog-to-digital
converter (ADC) where there are namely two things to consider, sampling frequency
(fs) and resolution. The sampling frequency determines the time each sample of data
is transformed from analog domain to digital. Nyquist criterion states that if you
want to recover or reconstruct a signal of given bandwidth fB from its digitized
version, the fs must be bigger then two times fB as shown in equation (2.18) [85].
fs > 2 · fB (2.18)
The resolution of the ADC can be represented as the least significant bit (LSB)
voltage, see equation (2.19). This simply means that the full scale voltage range
(VFSR) is quantized according to the number of bits (N) the ADC has [85].
LSB =
VFSR
2N
(2.19)
If a circuit has gain the smallest detectable change of a signal is referred to as
the sensitivity of the circuit shown in equation (2.20).
S =
LSB
Gain
(2.20)
2.6.2 Filtering
By fallowing Nyquist’s criterion you eliminate the possibility of any effect do to
aliasing, though the PPG signal is a slow one there are number of other factors
that affect the signal such as movement artifacts, 50Hz noise from electricity and
switching frequency of the LEDs. For our SpO2 measurements it can be expected
that the frequency of movements will be minimal above 0.5 Hz as estimation of the
frequency content of the accelerometer from previous implant, shown in Figure 2.20,
indicates. Figure 2.20 was created using Welch’s method [86] to calculate the power
spectral density (PSD). It shows intuitively the first 20min of the signal shown in
Figure 2.14 (a) where there is clearly no activity of the animal and the last 20min
where there is clearly much activity.
The problem with noise induced by movements is that if we eliminate the DC part
of the signal we remove the capability of measuring SpO2 by the principles of AC/DC
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Figure 2.20: PSD calculation of signal presented in Figure 2.14a showing the first
20min of the signal where there is no activity of the animal and the last 20min where
there is much activity. The frequency content is estimated with welch periodogram.
ratio as well as the option of measuring SvO2. The switching frequency of the red and
IR LEDs is from 100Hz in literature [87], though the standard switching frequency
is around 480Hz in most commercial devices [88]. This frequency becomes much
higher if certain power saving methods such as pulse-width-modulation (PWM) is
utilized.
As was showed in Section 2.3 the HR of the cattle is around 75-100 bpm and even
if it goes as high as 120-150 bpm the frequency content is still quite low. Thus a
low-pass filter with a pole around 6Hz is sufficient to receive the SpO2 signal. This
filter can be implemented either in analog or digital domain.
2.6.3 SpO2 calculation
Two main methods are utilized in the calculations of SpO2 so called Peak-and-Valley
method and Derivative method, both of these methods output what is called Ratio-
of-Ratios (ROS) and is simply the variable used to calculate the oxygen saturation
[55].
The peak-and-valley method described by Cheung et al. [89] extracts simply the
un-calibrated SpO2 value from the minimum and maximum intensities of the red
and IR wavelengths, see equation (2.21) and Figure 2.21 for clarification. Empirical
calibration curves such as the ones shown in Figure 2.7 are then used to calculate
the real saturation value.
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Figure 2.21: The figure shows graphical interpretation of the values used to cal-
culate ROS in equation (2.21), where the voltage represents the transmitted light
intensity. The signal is recorded with non calibrated meter using through finger
probe. The figure is adapted from [55] using recorded data from this thesis.
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)
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(
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) (2.21)
The derivative method can be explained as a computational simplification to the
peak-valley-method since it eliminates the need to calculate the natural logarithm
and thus it would suit better for implanted device. A 2-point derivative is calculated
between the maximum (t2) and minimum (t1) of the PPG signal of each wavelength,
the DC value (t3) is considered to be some point between the two points such as an
output from a low-pass filter with a very low cut-off frequency or an average of the
signal. Then the ROS can be calculated as shown in equation (2.22) complemented
with Figure 2.22 [55].
dIRED(t)/dt
IRED
dIIR(t)/dt
IIR
≈
IRED(t2)−IRED(t1)
IRED(t3)
IIR(t2)−IIR(t1)
IIR(t3)
=
ACRED
DCRED
ACIR
DCIR
= ROS2 (2.22)
The medical instrument manufacturer Masimo uses a more advanced pulse oxime-
try technology to calculate the oxygen saturation that accounts for separation of ve-
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Figure 2.22: The figure shows a graphical example of a PPG signal where the time
positions used for derivative calculation of ROS in equation (2.22) are shown for a
single wavelength. The DC and AC components of the signal are also pointed out for
further clarification. The signal is recorded with non calibrated meter using through
finger probe. The figure is adapted from [55] using recorded data from this thesis.
nous (non-arterial) blood and arterial or simply the DC and AC part of the signal.
Their technology is called Signal Extraction Technology (SET) and it is explained
so that the standard ratio technique in equation (2.15) does not account for any
pulsatile nature in the DC part that can occur during movements. Instead their
model estimates the noise and subtracts it from the PPG signal, further details
about the SET method is considered out of the scope of this thesis since it would
require significant time to explain but it has shown increased accuracy in estimating
the SpO2 during movement artifacts and moments of low perfusion [90].
Many oximeters output the average of the peak-and-valley such as taking 8 suc-
cessive maximas and 8 successive minimas to determine the SpO2 value. In those
cases the output is determined as mean-SpO2 (mSpO2).
2.7 Power consumption
One of the greatest challenges with implantable pulse oximeter is the amount of
power it consumes specially the LEDs driving current. Reichelt et al. used a driving
current of 20mA for the LEDs in their proposed implantable meter [14]. Latest
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Table 2.5: Comparison of power consumption of Tavakoli et al. meter compared
to commercial meters manufactured by Nonin. Total Power means only the LED
power and processing power excluding the display of the signal. Reconstructed from
[87]
Pulse Oximeter Total Power Days in Operation on
Version Consumption 4 "AAA" Batteries
(≈ 2306mAh)a
Tavakoli et al chip 4.8mW 60
WristOx®3100 ≈ 60mW 5.2
Xpod 60mW 4.8
Ipod 60mW 4.8
Avant®4000 71mW 4
PalmSAT®2500 ≈ 80mW 3.6
Onyx®9500 ≈ 120mW 2.4
8500 Series ≈ 130mW 2.2
aThere is no capacity value given in [87] for the AAA batteries they
used, but an estimation of 2304 mAh was calculated by assuming a 3.0V
supply voltage
implant of the Remowel group [1] used a battery LS14500 by Shaft with capacity
of 2600mAh. That would mean only around 130 hours (≈ 5.4 days) of continuous
supply current for the LEDs. If we combine that value to the theoretical mean
current consumption (2.35mA) of previous implant this value would be even less,
only about 4.8 days of continuous measurements.
Tavakoli et al. published a paper in 2010 called "An Ultra-Low-Power Pulse
Oximeter Implemented With an Energy-Efficient Transimpedance Amplifier" [87].
They introduce a pulse oximeter with a novel transimpedance amplifier, as well as
analog domain signal processing methods that save power compared to methods
conducted with a digital-signal-processor (DSP). In their paper they made a com-
parison of processing power between several low-power commercial pulse oximeters
manufactured by Nonin Inc. which can be considered one of the leading companies
of pulse oximetry devices[91]. Table 2.5 shows the total power consumption (LED
power and processing power) of their chip compared to the commercial Nonin Inc.
meters. Though there is no value given for the capacity of the batteries used it can
be estimated that the supply voltage they use is around 3 V and thus a mean supply
current of 1.6mA, this should not be taken literally since it is just an estimation the
author of this thesis makes.
Sixty days of continuous measurements makes implantable pulse oximetry become
a realistic option for respiratory monitoring and diagnosis in dairy-cattle. Since the
application would have to be implanted in the animal ideally for 3-6 months. That
recording time could easily be obtained by limiting the sampling periods to for
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example ten minute period every one hour increasing the operating time six times.
It can still be seen from Tavakoli et al. article that the oscillator/LED and switching
control makes up 91.5 % of the chip power consumption or 4.48mW. In the appendix
of their paper they derive an equation for the total power consumption of the LEDs
and photoreceptors (see equation. (2.23)) and explain how much less they could
theoretically reduce the power consumption of their meter.
P ′TOT (x) w P ′LED + P ′PR = (4.4mW )x−1 + (80µW )x2/3 (2.23)
Where P ′LED is the LED power and P ′PR is the power consumption of the pho-
toreceptors. From Equation. 2.23 there is a optimum point where the total power
consumption (PTOT ) is minimum, namely when x = 14.1. This indicated that either
the gain of the chip could be increased by a factor of 14.1 or the LED power could
be decreased by 14.1. Both options would reduce the total power consumption from
PTOT = 4.48mW to P ′TOT = 780µW or a reducing factor of 5.7. Tavakoli suggests
that decreasing the duty cycle of the chopped LED pulses or the LEDs drive cur-
rent is the only true option since increasing the gain of their amplifier would not
help because the photoreceptor power would exceed the LED power. The minimum
LED generated photo-current applicable would then be 3.5nA compared to the 50nA
typical value of their oximeter [87]. According to Tavakoli et al. when such a low
photo-current is generated the sensor becomes more sensitive to mainly two factors,
that are 1) ambient light and 2) minimum detectable contrast. By implanting the
sensor, it is easy to imagine that ambient light will be eliminated quite easily since
the skin of the cattle is hairy and quite thick. Tavakoli also showed that at 3.5nA
photocurrent the minimum detectable contrast is 0.1% which is lower than the low-
est typical value of AC/DC contrast. As stated earlier in section 2.2.2, Reichelt
et al. proposed implantable ring probe shown in Figure 2.12 showed a contrast of
20%-40% AC/DC level contrast but their probe was attached to the artery directly.
Another power limiting factor to the implantable system is the power consump-
tion of the ADC, Sharpeshkar states that several ADC have a power consumption
that can be described by the law presented in equation (2.25) [92]. This is simply a
trade-off between the resolution of the ADC and the sampling frequency.
PADC ∝ fs · 2N (2.24)
PADC = Eq · fs · 2N (2.25)
Where Eq is a relative constant that represents the energy per quantization level
and is often referred to as figure of merit (FOM) [92].
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3. METHODS
In this chapter we will describe the oxygen saturation meter system developed for
this thesis as well as describe the testing procedure and setup. Several prototypes
where developed for this thesis, starting from acquiring a basic PPG signal with a
LED and a phototransistor. The device described in section 3.1 is the final proto-
type developed for raw signal measurements. The section justifies the circuit design
and component use. Section 3.2 reviews the design/integration of the probe and
biocompatability issues towards the design, such as the coating process. Section
3.3 explain the signal processing implementation used in to acquire the results pre-
sented in Chapter 4. Finally Section 3.4 introduces the experimental setups used to
determine the functionality of different components of the oximeter.
3.1 Device : design and components selection
The implantable oxygen saturation meter developed has two main requirements to
fulfil, first it has to be biocompatible since any non-biocompatible material is rejected
by the body causing inflammation and other side effects. Secondly it has to be able
to acquire sufficiently high SNR to measure the signal. It is thus important that the
measurement device has an adaptive LED current control. Adaptive element such
as these are often called Automatic-Gain-Control (AGC) feedback systems. A block
diagram of the measurement device is shown in Figure 3.1. It is made out of three
functional blocks as seen on the figure:
1. Probe : Includes the Red and IR LEDs as well as the photosensor.
2. Analog Circuit : Incorporates the transimpedance amplifier, switching cir-
cuit the AGC as well as analog filters and amplification.
3. Microcontroller Unit (MCU) / DSP : Creates the square wave that drives
the switching circuit of the LEDs and it also samples and stores the signal data.
The functional blocks where designed so that is is easy to change and test certain
parts of the system individually. Most of the prototypes where run with a 555
timer instead of a MCU and both reflectance probes and a through tissue probe was
developed to ease the testing.
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Figure 3.1: Block diagram of the measurement device
3.1.1 Transimpedance amplifier
The most important part of the analog circuit is the transimpedance amplifier. Our
device utilizes the classic approach of using a linear transimpedance amplifier, the
OPA380 from texas instruments. Figure 3.2 shows a linear transimpedance pho-
toreceptor. The OPA380 is a high-performance transimpedance amplifier that is
able to operate with a supply voltage of +2.7V to +5.5V and it also has a very low
1/f noise, low input bias current, low input voltage and wide bandwidth [93]. The
version of the device presented in this thesis has a transimpedance gain of 120 dB
(V/A), meaning that a photo-current of 10nA generates a 10mV output. The major
downside to the transimpedance amplifier used is the quite high quiescent current of
≈ 6mA. One solution to that problem would be to utilize a transimpedance amplifier
proposed by Tavakoli et al. in [87]. The current consumption of two transimpedance
amplifiers that Tavakoli used was only 80µW . Their amplifier is described in detail
in [31] and [87] but its manufacturing was considered too complex for the scope
of this thesis. Tavakoli et al. amplifier also utilizes a logarithmic response tran-
simpedance amplifier, see Figure 3.3 for basic operation principles. It utilizes an
NMOS transistor in the feedback loop of the amplifier and operates in subthreshold
regime of operation because the photocurrent is so small and thus it exhibits an
exponential I-V characteristics. This would be ideal for most SpO2 measurement
systems, but since there is quite much uncertainty with our measurement signal we
don’t want to limit our option of measuring the SvO2 since it is the only signal
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that has been retrieved from clinically tested implantable meters utilizing the pulse
oximetry principles as stated in Section 2.2.2.
−
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Rf
vout
Figure 3.2: Linear transimpedance am-
plifier [94].
−
+
V+
vout
Figure 3.3: Logarithmic transimpedance
amplifier [87].
3.1.2 Filters
The PPG signal used to determine the oxygen saturation is a slow varying signal
as can be seen from Figure 2.21. A high bandwidth photoreceptor is important so
that the photoreceptor is able to settle down during the short pulse from the LED.
We can then easily filter the signal with a low pass filter at 5-10Hz to retrieve the
PPG signal as seen from the block diagram in Figure 3.1. This filter also serves as
a antialiasing filter for the ADC, its performance on attenuating higher frequencies
such as switching frequency and 50Hz noise should be considered. The other filter we
utilize in the feedback loop is to acquire the DC part of the signal. Both filters in the
prototypes are standard passive 1st degree filters see Figure 3.4 and the frequency
response in Figure 3.5. The choice of filtering method is justified with its simplicity
and the easy of changing components to acquire different frequency response, that
can be set with equation (3.1).
fc =
1
2pi ·R · C (3.1)
3.1.3 AGC and switching circuit
The switching circuit utilizes a simple npn-transistor circuit that switches between
the red and IR LEDs (see Figure 3.6), depending on a square wave created with
the MCU of the measurement device. That is the transistor is utilized as a switch
that is turned on when voltage to base (B) is high relative to emitter (E), Figure
3.7 shows a standard representation of an npn transistor [94]. The switching circuit
is driven with a voltage coming from the photoreceptor where the DC part is first
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Figure 3.4: Standard passive 1st-degree
low-pass filter [94].
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Figure 3.5: Frequency response of a 1st
degree low pass filter with cut-off frequency
6Hz. Created from [95].
acquired with a Low-Pass filter and then an integrator is used to drive the voltage
to an optimized level, this level has to be determined experimentally according to
the amplitude of the AC/DC part expected from the signal. In this thesis it was set
to 1/2 Vcc. The AGC regulation supplies the LEDs with a current determined by
the output voltage of the AGC over the LED resistors, in this thesis we refer to this
as LED drive current or LED supply current, it can be determined with equation
based on Ohm’s law, equation (3.2).
ILED Supply =
(VAGC − Vf )
RLED Supply
(3.2)
Where the value of the supply resistor determines the supply current range de-
termined by the voltage (VAGC − Vf ) where (Vf ) is the forward voltage of the pho-
todiode. The final stage amplification has to be determined experimentally to avoid
saturation of the output, but an amplification of five was used in this thesis. The
circuit schematics are shown in Appendix B.
660nm 880nm
B
A
Figure 3.6: Circuit schematic of Ad-
vanced Photonics dual LED chip E838
[96].
B
C
E
Figure 3.7: Standard representation of
an NPN transistor. Collector(C) (n-type),
Base (B) (p-type), and emitter (E) (n-
type) [94].
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3.2 Probe design
A major part in the design of the implantable pulse oximeter is the probe since there
are two issues that have to be taken into consideration that are not a big factor
in normal external SpO2 measurements. Namely bio-compatibility of the probe
as well as temperature effect of the LEDs on internal tissue. The probe includes
a photodiode as well as red and IR LEDs. Both components are not available
commercially in bio-compatible form, thus they have to be sealed or coated before
implantation. A image of the uncoated probe is presented in Figure 3.8.
Figure 3.8: A photograph of un-coated
transreflectance probe developed for this
thesis. It consists of PDI-E838 dual
LED chip, a barrier made out of black
Polyoxymethylene (POM) plastic and a
BPW34S photodiode. The scale of the fig-
ure is in cm.
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Figure 3.9: Relative Spectral Sensitivity
as a function of wavelength for the photo-
diode BPW34 [97].
The LEDs it uses is a dual chip manufactured by Advanced Photonics with red
(λ = 660nm) and IR (λ = 880nm) LEDs, called PDI-E838. Figure 3.6 shows a
circuit schematic of the chip, it comes in a small plastic surface mount technology
(SMT) package with dimensions 4.24mm x 6.35mm [96]. The choice of the IR
λ = 880nm, was justified from Medtronics 4327A pacing lead that was the only
implantable oxygen saturation system tested clinically. It measured SvO2 [49] as
explained earlier in Section 2.2.2. More commonly used wavelengths for the IR
LED are 900nm and 940nm , they are used in most commercial devices and usually
justified from the extinction coefficient as shown in Figure 2.3 [98]. Since we are
concerned about the fat tissue surrounding the implant 880nm has lower µa then
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940nm according to Figure 2.17 which is another reason to justify the choice. The
photodiode used was an Osram BPW34S that has good relative spectral sensitivity
for the wavelengths we are using see Figure 3.9, it has Vf = 1.3 V [97].
3.2.1 Coating process
The two methods used for the coating of the device are very different. EPO-TEK
301-2FL epoxy is a thermosetting polymer made out of two components having a
specific gravity of SGA = 1.06 and SGB = 0.89. The datasheet of the material
provides the ratio of mixing by weight as 100:35, then once the two materials are
mixed their curing time is 3 hours at 80 ◦C or 3 days at 23 ◦C [82]. The epoxy is
pourable liquid when mixed so the use of a cast is required. Figure 3.10 shows a
photo of the cast that was manufactured to coat the probe. The cast is made out
of Teflon where four stainless steel spikes have been placed to hold the probe and
determine the thickness of the epoxy layer, the spikes can be moved to change the
thickness of the layer if further coating tests are needed.
Figure 3.10: Figure shows the cast manufactured for the epoxy coating, it is made
out of Teflon with stainless steel spikes that can be varied in hight and thus it is
possible to change the thickness of the epoxy layer. The scale in the figure is in cm.
Figure 3.11 shows a cross-sectional view of the probe. To utilize the optical
properties of the epoxy it is important to empty all air bubbles from the mixed
material before curing starts, that can be done in a vacuum chamber. The thickness
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of the epoxy was set to be 3.5mm from the PCB board, this was done to test the
coating effect with thick layer of coating but not for any optimization purposes.
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Figure 3.11: Cross-sectional image of the probe showing different components as
well as the thickness of the epoxy coating.
Parylene-C coating has different and more complex coating procedure compared
to epoxy. Figure 3.12 shows the block diagram of the processing method, which can
be explained in three steps according to parylenengineering [99] :
Dimer 
Input Vaporizer Pyrolizer
Deposition 
Chamber
Cold 
Trap
Vacuum 
Pump
150°C
1 Torr
650°C
0.5 Torr
25°C
0.1 Torr
Figure 3.12: Block diagram of the processing method for Parylene-C coating ac-
cording to parylenengineering [99].
1. A dimer called di-para-xylene is a chemical precursor to Parylene-C coating.
It is in the form of granular white powder. When it is heated to ≈ 150 ◦C at
1 Torr, it converts to a gaseous state.
2. The vapor is then fed into a pyrolizer at 650 ◦C at 0.5 Torr, that forms a
gaseous monomer.
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3. The monomer is then fed into a coating chamber at room temperature (25 ◦C)
at 0.1 Torr. The monomer gas condenses equally on all surfaces and then
polymerizes to a product with high degree of crystallinity.
The cold trap is a steel thimble that is cooled with liquid nitrogen. The thim-
ble condenses the Parylene-C process by-products and prevents any contamination
to the vacuum pump that maintains the vacuum in the system [100]. Before the
Parylene-C process the printed circuit board (PCB) is cleaned, first with Isopropanol
for 15 minutes then with a mixture of Saline, de-ionized water and Isopropanol for
30 minutes and again for 15 minutes with Isopropanol. This cleans the PCB so that
the Parylene-C coating attaches better to the surface. Figure 3.13 shows how the
Parylene-C layer is distributed over the probe.
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Figure 3.13: Cross-sectional image of the probe showing different components as
well as the thickness of the Parylene-C coating.
3.2.2 Temperature effect
When discussing temperature effect the main concern is thermal radiation from
the LEDs and how it might have destructing effects on the internal tissue when
it is absorbed. Another thing is how increased temperature in the implant might
effect the temperature sensor in the existing implant. This has to be measured and
concluded as well as to measure how the coating of the implant effects this thermal
radiation.
3. METHODS 45
3.3 Signal processing implementation
To acquire the oxygen saturation value a post processing script was written in MAT-
LAB. A flow chart of the processing method is presented in Figure 3.14, where the
raw signal is acquired from the ADC. The peak detection blocks utilize a function
written by Eli Billauer for peak detection in noise, it is distributed without any
copyright and for public use [101]. The function fits perfectly to our use and enables
us to extract all info without any pre or post filtering. The first peak detection block
is used to find the maxima and minima of the raw signal, this enables us to separate
the red and IR signal in separate vectors.
Raw Signal 
(ADC)
Peak 
Detection
IR / RED 
Separation
Peak 
Detection
DC 
Extraction
Ratio 
Calculation
SpO2 
Calculation
HR 
Calculation
Figure 3.14: Flow chart of the signal processing for equation (2.22), HR can be
easily extracted though it is not our main objective and methods for HR extraction
are not presented in this thesis.
The flowchart of Figure 3.14 is for SpO2 calculation from equation (2.22), this
means that we need to extract the DC part of each signal. Since there is no baseline
drift in the test measurements we do this simply by taking the average of each
signal. The second peak detection block then extracts the minima and maxima
of the signals (peaks-and-valley), Figure 3.15 shows how these two peak detection
blocks work in extracting the information from the signal. The ratio calculation
block uses equation (2.22) to calculate the the ratio. Then the final block uses
equation (2.16) to calculate the SpO2. This algorithm calculates un-calibrated SpO2
as stated earlier in Section 2.6.3, but it gives a comparison value between different
measurement setup. The same flow chart also applies to equation (2.21) the only
difference is the DC extraction block is not needed.
In Chapter 4 the ratio was calculated with the peak-to-valley method, presented
with equation (2.21) from Section 2.6.3. It is not convenient method for DSP use
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Figure 3.15: Figure shows the raw signal data, the IR and red data as well as the
minima and maxima of each signal used to calculate the ratio with equation (2.21)
or (2.22).
since it uses natural logarithm for calculations, but since our algorithm utilizes MAT-
LAB it is a slightly more accurate method. The ratio computations are presented
in all relevant measurements derived from 5-8 minima and maxima and presented
as mROS1 for mean values. Since the signal is unambiguous it is not possible to ac-
quire the noise derivation from the mean, so called root-mean-square (RMS) value
and thus a single numerical value for the SNR is also not possible. This thesis thus
focuses on presenting the mROS values with the standard deviation (σ) as presented
in equation (3.3).
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σ =
√√√√( 1
n− 1
n∑
i=1
(xi − x¯)2
)
(3.3)
Appendix A shows the MATLAB algorithm used to generate the result of all
mROS calculations in Chapter 4, it presents methods for calculating the SpO2 with
both equation (2.21) and (2.22). Depending on the signal acquired some manual
threshold changes might be needed to ensure the accuracy of the algorithm.
A common filter method used to smooth the data is to use a moving average filter
on the extracted IR and red signal and then find the maxima and minima. The 4-
point moving average filter used in some calculations of Chapter 4 can be described
with the difference equation (3.4). Figure 3.16 shows a graphical interpretation of
this 4-point and 8-point moving average filter on a IR, PPG signal. It is clear from
the figure that it smooths out the data considerably thus lowering the σ of the signal.
y(n) =
1
4
x(n) +
1
4
x(n− 1) + 1
4
x(n− 2) + 1
4
x(n− 3) (3.4)
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Figure 3.16: Raw signal showed in comparison with signal filtered with a 4-point
moving average filter shown in equation (3.4) and an extended 8-point moving aver-
age filter.
3.4 Experimental testing of the device
There are numeral tests that where performed on the device, listed below:
1. Base testing with constant current
2. AGC testing on final version of device
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3. Absorption due to epoxy coating
4. Absorption due to Parylene-C coating
5. Thermal radiation/effect of LEDs
6. Absorption of cattle fat tissue
Two measurement systems where used to acquire the measurement results. The
first one (Oxmeter 1) is composed of three separate units, a 555 timer running
at 715Hz combined with switching circuit, separate analog circuitry with a tran-
simpedance amplifier, low-pass filter and non-inverting amplifier. The last part is
an Tektronix TPS2014 oscilloscope with ADC. Oxmeter 1 has no AGC regulation
and thus supplies constant current to the LEDs. The reason why the system was
developed in separate units is the ease of changing the design, frequency of the timer
and sampling frequency and resolution of the AGC. It thus has a convenient testing
mechanism and it is possible to receive experimental data that can further improve
the design of the final device. Oxmeter 1 was used for test measurements nr.1 and 3
to 6 with a constant LED drive current of 1mA, since the final system has to be low
power the LED drive current was decided from initial tests and it was determined
that a sufficiently good signal could be acquired with 1mA drive current.
For the base testing of the device main concern was to utilize the transreflectance
probe, a signal was recorded with every finger of a single subjects hand. The signal
was extracted so that about 10 minima and maxima were recorded when the subjects
finger was sill and minimal motion artifacts or baseline drift where effecting the signal
acquisition. Then the mROS1 value where calculated with equation (2.21), mSpO2,
standard deviation and the difference from mean value where calculated.
The second system (Oxmeter 2) is a individual system that has a microprocessor
protoboard (MSP430F1611) connected to a analog circuit, it is connected through
RS232 serial-to-usb converter with a laptop that utilizes MATLAB to acquire the
signal and process it. The block diagram of Figure 3.1 describes Oxmeter 2 accu-
rately. It has a AGC feedback that enables it to change the LED drive current from
1.3mA to 2mA, this resolution can be further modified and increased by changing
a set of resistors. The results for test measurements nr.1-2 are presented in Section
4.1.
Each probe is measured with same set of basic tests, as described above, before
coating and after coating. That gives an estimate on both the intensity changes
caused by coating as well as changes in mROS1 values that are used to compute the
mSpO2. A single thickness of coating was manufactured with each coating method
due to fabrication cost of the probe. The results from measurements nr.2 and 3 are
presented in Section 4.3.
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The temperature effect of the LEDs was tested with a constant supply current
of 1mA and 7mA. A dual output, Fluke 52II temperature meter was used where
the environmental temperature was measured with one thermocouple probe and the
other thermocouple was placed directly on top of the PDI-E838 to measure the
thermal radiation or surface temperature. The Fluke 52II model has an accuracy of
±0.3 ◦C [102]. The results from these measurements are presented in Section 4.2.
It was stated earlier in Section 2.1.1 that light can penetrate several millimetres
in tissue and the associated scattered light several centimetres, it has also been
stated in Section 2.4.2 that previous implantation places have included considerable
amount of fat tissue. Yet another statement previously concluded in Section 2.1.3
that it is very hard to model the absorption and scattering of the composition of
different tissue. The effect of fat tissue was measured by using similar measurement
setup as previously, placing fat layers of different thickness on top of the probe and
placing the thumb on top of that layer. Then the thickness of layers where varied
from 0.5mm to 4mm, the results from this test measurement (nr. 5) are presented
in Section 4.4.
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4. RESULTS
Section 4.1 starts the chapter by presenting the measurement systems and a sim-
ple technical performance measurement that where conducted on the devices. The
following sections then present different measurement result. Section 4.2 presents
results from thermal radiation measurements. Section 4.3 presents the results from
different coatings on the probe and Section 4.4 presents results from adipose tissue
measurements.
4.1 Measurement system
As described earlier in Section 3.4, two devices where developed for the thesis and
they where named Oxmeter 1 and Oxmeter 2. Figure 4.1 shows the MSP430 proto-
board and PCB of Oxmeter 2. The boards are connected together with four wires,
namely square wave output of processor to input on the oximeter, amplifier output
to ADC input, supply voltage and ground. The main difference between the pro-
totypes is difference in supply voltage, square wave frequency, sampling frequency
and resolution of the ADC, but they utilize the same analog circuit and probe.
Figure 4.1: The figure shows MSP430F1611 protoboard connected with the Oxmeter
2 PCB.
Table 4.1 shows the technical specifications of both systems. The most interesting
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parameters are the AGC in Oxmeter 2 that enables a LED drive current of 1.3-2mA
and a slightly lower value of LSB that effects the resolution of the ADC.
Table 4.1: Table showing the technical specifications of both measurement systems,
Oxmeter 1 and Oxmeter 2.
Oxmeter 1 Oxmeter 2
Supply Voltage 4.5V 3.3V
LED drive current ≈ 1mA 1.3-2mA
Sampling Rate 250Hz ≈ 1kHz
Square Wave Frequency 716Hz ≈ 200Hz
LSB 78 µV 0.61 mV
The ADC of the MSP430F1611 is 12-bit and it uses a reference voltage of 2.5V to
have as high resolution as possible, hence the LSB is 0.61mV [103]. The sensitivity
of the amplifier can be increased with amplification as shown earlier with equation
(2.20). The TPS2014 oscilloscope utilizes 8-bit vertical resolution for the ADC [104],
meaning that the window size used to view the signal is important. In this thesis
all signals where acquired with 20mV resolution per window.
The relationship between the 2.5V reference voltage of the AGC and the 3.3V
supply voltage of Oxmeter 2 works so that an integrator in the AGC feedback is
fed with a certain reference voltage (for example 1/2 Vcc) and the LEDs are then
controlled by the output of the integrator. If the DC level from the photosensor is
less then 1/2 Vcc the output of the integrator will rise linearly until it reaches 1/2
Vcc and the opposite goes if the DC level is higher. A good design technique is
to include amplification in the integrator circuit so that it matches the gain of the
output amplifier, in our case 5. This changes the behaviour of the integrator from
linear to charging behaviour set by the time constant of the integrator circuit. The
complete circuit schematic can be seen in Appendix B.
Increasing LED supply current increases both the DC and the AC part of the
signal amplitude. Figure 4.2a shows a signal acquired with 1mA supply current to
the LEDs and Figure 4.2b shows a signal acquired with 7mA supply current to the
LEDs. It is evident from those figures that the amplitude of both AC and DC level
increases with higher LED supply current, in the case of Figure 4.2 the values almost
double.
As stated earlier in Section 3.3 the signal is unambiguous and thus we can not find
the SNR, we thus present theROS1 with the standard deviation to give some estimate
of the error. Table 4.2 shows the measurement result for Oxmeter 1. The table shows
the ROS1 with standard deviation, as well as uncalibrated SpO2 value derived with
equation (2.16) and finally the difference between average SpO2 measurement and
each measurement spot. It is shown in Table 4.2 that the average σ is around 8%,
that is a quite high value and indicates that a moving average filtering should be
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Figure 4.2: The figure shows two IR signals extracted from measurements done with
(a) 1mA LED supply current and (b) 7mA LED supply current. The raw signal is
shown with red cut line while the black line shows the filtered signal, filtered with a
4-point moving average filter presented in equation (3.4).
applied on the signal prior to ratio calculation such as shown in Figure 3.16.
Table 4.3 shows the same results as Table 4.2 but for Oxmeter 2, that the average
σ presented is around 9% which is quite much higher than for Oxmeter 1. The
variation between the average of calculated mSpO2 and each measurement spot is
only around 1%.
The data of Oxmeter 2 where also used to see how the moving average filter
presented with equation (3.4) effects the σ of the measurements. The results can be
seen in Table 4.4, it is evident from that result that changes in ROS1 are minimal but
the σ is effected greatly since noise is reduced. The average σ for 4-point moving
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Table 4.2: Oxmeter 1 data showing the mROS1 calculated from eight minimas and
maximas with equation (2.21). Standard deviation (σ) as described by equation (3.3),
uncalibrated mSpO2 derived with equation (2.16) and the difference (∆) between
average mSpO2 of all fingers and mSpO2 of each finger.
Finger mROS1 σ mSpO2 [%] ∆
#1 1.07 ± 0.10 72.05 -2.49
#2 0.99 ± 0.05 74.66 +0.12
#3 0.96 ± 0.06 75.73 +1.19
#4 1.02 ± 0.04 73.83 -0.71
#5 0.97 ± 0.07 75.44 +0.90
#6 1.01 ± 0.07 74.19 -0.35
#7 0.99 ± 0.10 74.64 +0.10
#8 1.05 ± 0.14 72.87 -1.67
#9 0.96 ± 0.08 75.64 +1.10
#10 0.996 ± 0.08 76.35 +1.81
Average 0.996 ± 0.08 74.54
Table 4.3: Oxmeter 2 data showing the mROS1 calculated from eight minimas and
maximas with equation (2.21). Standard deviation (σ)as described by equation (3.3),
uncalibrated mSpO2 derived with equation (2.16) and the difference (∆) between
average mSpO2 of all fingers and mSpO2 of each finger.
Finger mROS1 σ mSpO2 [%] ∆
#1 0.98 ± 0.13 75.24 +1.62
#2 1.02 ± 0.05 73.74 +0.12
#3 1.05 ± 0.10 72.70 -0.92
#4 1.05 ± 0.06 72.64 -0.98
#5 0.99 ± 0.06 74.72 +1.10
#6 1.03 ± 0.06 73.32 -0.30
#7 1.04 ± 0.10 73.18 -0.44
#8 1.06 ± 0.15 72.67 -0.95
#9 1.01 ± 0.05 74.14 +0.52
#10 1.02 ± 0.17 73.81 +0.19
Average 1.03 ± 0.09 73.62
average filter is only around 3.9% and for the 8-point moving average filter it is
around 2.7%. It is important to limit the number of sample points used in a moving
average filter since it creates a delay when processed with a DSP as well as reducing
the amplitude of the signal. A optimal ratio between the length of a moving average
filter and the sampling frequency was not determined in this thesis.
4. RESULTS 54
Table 4.4: The table shows measurements conducted with Oxmeter 2 and presented
earlier in Table 4.3, where the IR and red signals where filtered with both 4-point
and 8-point moving average filter presented earlier with equation (3.4). The ROS1
and σ values are given for every finger measured.
Finger mROS1 σ mROS1 σ
4-point 4-point 8-point 8-point
#1 0.96 ± 0.033 0.96 ± 0.016
#2 1.01 ± 0.047 1.00 ± 0.041
#3 1.02 ± 0.033 1.00 ± 0.028
#4 1.00 ± 0.011 1.01 ± 0.031
#5 1.01 ± 0.015 1.00 ± 0.010
#6 0.98 ± 0.036 1.00 ± 0.015
#7 0.99 ± 0.042 0.97 ± 0.024
#8 1.06 ± 0.070 1.01 ± 0.065
#9 1.00 ± 0.039 1.00 ± 0.042
#10 0.94 ± 0.063 0.95 ± 0.021
Average 1.00 0.039 1.09 0.029
4.2 Measurement of the thermal radiation of probe and coat-
ing
Temperature measurements where conducted by placing a double wired thermocou-
ple directly on top of the LEDs and keeping it in place with a plastic clip, another
thermocouple was placed freely measuring room air temperature at the same time.
The temperature was measured with LED supply current of 1mA which was the
supply current used in most experiments and with a LED supply current of 7mA.
Table 4.5 shows the average temperature of the probe as well as the difference be-
tween environmental temperature and the thermocouple that is placed on top of
the LEDs. As stated earlier in Section 3.4 the accuracy of the thermometer used
is ±0.3 ◦C. Difference of measurements between environmental and probe was only
around 0.05 ◦C for a LED supply current of 1mA, and it was inside the accuracy
limit for 7mA LED supply current.
Table 4.5: Temperature measurement of probe where thermocouple was placed di-
rectly on top of the LEDs and the temperature measured for 15 minutes every 20
seconds. Measurements where done with constant LED driving current of 1mA and
7mA. The average temperature is presented as well as the average difference (∆)
between environmental temperature and LEDs temperature.
LED Drive - Average
Current Temperature [ ◦C] ∆ [ ◦C]
1mA 21.64 ± 0.09 0.35
9mA 24.02 ± 0.51 0.10
4. RESULTS 55
According to Walsh [105] it is possible to calculate the temperature rise for a
short pulse of light following the principle that heating of a material with light is
dependent upon absorption. Equation (4.1) shows this relationship where He is the
surface radiant exposure given in units (Jcm−2), ρ is the density and c is the heat
capacity. Walsh gives a reasonable estimate for ρc in tissue as ρc ≈ 4.2 Jcm−3 ◦C
and µa = 50 cm−1.
∆T =
µa ·He
ρ · c (4.1)
In the datasheet of our LEDs we are given the radiant flux (PO) = 2.4 mW at λ
= 660nm and PO = 1.8 mW at λ = 880nm for a supply current of 20mA [96]. We
can relate this value to He by presenting equation (4.2) where Ee is the irradiance or
the PO incident on a surface. This means the temperature rise in tissue depends on
the surface area exposed and the time it is exposed. Equation (4.3) is an expansion
of equation (4.1) and combines this relationship. Where t is time of exposure and
A is the surface area light is incident on.
He = Ee · t = PO
A
· t (4.2)
∆T =
µa · POA · t
ρ · c = 2.857
[
µm2 · ◦C
s
]
· t
A
(4.3)
Example is an area of the size 1mm x 1mm = 1 µm2 and a pulse duration of 0.01
sec, gives ∆T = 0.02857 ◦C.
There are two things equation (4.1) does not account for. First that there is
no diffusion during the pulse, this becomes an issue if the duration of the pulse is
shorter then the thermal relaxation time defined with equation (4.4). There Walsh
gives an estimate of thermal diffusivity in human tissue as α ≈ 1.3 · 10−3 cm2s−1
and r is defined as the characteristic dimension of the absorbing target [105].
τp ≈ r
2
4α
(4.4)
For the thermal relaxation time to be shorter than a pulse of 0.01 sec the surface
area has to be larger than 5.2 ·10−9m2 or a circular object of diameter 82µm, if
not the tissue is cooled with diffusion. Secondly equation (4.1) does not account
for any scattering, scattering can cause the local fluence (ψ) to be larger then He
and thus it should be replaced with (ψ) in equation (4.1). It is quite obvious from
these calculations that thermal effect of LEDs inside tissue is minimal and further
theoretical accuracy is considered out of the scope of this thesis since it won’t be of
any value to the measurement system presented in this thesis.
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4.3 Measurement of the effect of coating on the probe
The measurements done to estimate the effect of coating on the probe where con-
ducted with three types of coating/probes as stated earlier; non-coated, epoxy-
coated and parylene-C coated. The measurements where conducted with constant
LED drive current of 1mA and with as similar measurement setup as possible before
coating and after coating. The same probe was tested before and after coating, it
was not possible to determine the exact amount of ambient light or environmental
effect on the measurements other then all lights where turned off and the room kept
dark to ensure minimum effect of outside ambient light or ambient light and 50Hz
noise from room lights. The epoxy coated probe will be referred to as probe nr.1
and the Parylene-C coated probe will be referred to as probe nr.2 in some occasions.
4.3.1 Epoxy coating
Figure 4.3 shows the probe after being coated with epoxy, due to fabrication tech-
niques the epoxy was slightly matt on the surface. The cast used to fabricate the
probe was presented earlier with Figure 3.10 in Section 3.2.1. Table 4.6 shows the
measurement data from the epoxy probe prior to coating (No-Coating) and after
coating (Epoxy-Coating). The mROS1 values that are given are calculated from
equation (2.21) and an average value is calculated from 7 raw signal minimas and
maximas.
Table 4.6: Table shows measurements done on a single subject fingertips. The
same probe was measured before and after coating with EPO-TEK 301-2FL medical
grade epoxy. mROS1 shows the average of 7 maximas and minimas as calculated with
equation (2.21). ∆ shows the difference between the coated and un-coated probe.
Finger mROS1 mROS1 ∆
No- Epoxy-
Coating Coating
#1 1.04 1.01 0.03
#2 1.00 0.97 0.03
#3 1.02 1.01 0.01
#4 1.02 1.08 -0.06
#5 1.02 1.06 -0.04
#6 1.02 0.97 0.05
#7 0.95 0.99 -0.04
#8 1.04 0.98 0.06
#9 1.04 1.05 -0.01
#10 1.08 1.09 -0.01
Average 1.023 1.021 0.002
It is important for the instrument design to present the difference in signal am-
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Figure 4.3: The figure shows a measurement probe after being coated with 3.5mm
thick layer of epoxy. The scale of the figure is in cm.
plitude of the coated and un-coated probe. Figure 4.4 presents a bar chart of the
DC level for the IR light measured from probe nr.1 before coating and after coating
from a continuous recording of 10 seconds.
Table 4.7 presents the value of both DC and mean AC part of both wavelengths for
the same signals as where presented in Figure 4.4 where the AC part is calculated
from seven consecutive maximas and minimas. The last result presented for the
epoxy coating is a graphical representation of the acquired signal. Figure 4.5 shows
the signal before and after coating, the signals are presented as raw and filtered data
with a 4-point moving average filter presented in equation (3.4).
Table 4.7: The table shows amplitude recieved from the separated LEDs with the
probe prior to coating and after being coated with epoxy. The DC values are calculated
as average from 10sec recording and presented as DC. The mAC part is calculated
as the average amplitude between seven maxima and minima.
Measurement DCIR DCRED mACIR mACRED
[V] [V] [V] [V]
No-Coating 0.913 0.905 0.027 0.027
Epoxy-Coating 1.987 1.982 0.015 0.016
As shown previously in Section 4.1 the σ drops significantly when the signal is
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Figure 4.4: The bar chart shows the DC level of IR light measured with probe nr.1
before coating (No-Coating) and after coating (Epoxy-Coating).
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Figure 4.5: The figure shows the IR signal acquired with probe nr.1 before coating
(No-Coating) and after coating (Epoxy). The signals are presented as raw and filtered
data with a 4-point moving average filter presented with equation (3.4).
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filtered with a moving average filter. It can be seen graphically from Figure 4.5
that the noise level for the epoxy coated probe is higher after the coating than
before coating, this is partially explained by higher DC amplitude and lower mAC
amplitude.
4.3.2 Parylene-C coating
The Parylene-C coating is very different from the epoxy coating as shown previously
with the processing steps in Section 3.2.1, Figure 4.6 shows the probe after coating.
It is evident from the figure that the coating is not visible and it can be hard for the
naked eye to determine if a probe has been coated or not. This can easily be tested
with a multimeter to see if there is contact in the ground plane.
Figure 4.6: The figure shows a measurement probe after being coated with 15 µm
thick layer of Parylene-C. The scale of the figure is in cm.
The Parylene-C coated probe was tested in the same way as the epoxy coated
one, that is before and after coating measurements where conducted with constant
LED drive current of 1mA. The results from those measurements can be seen in
Table 4.8, where it can be seen that the average change in mROS1 is only 0.004
between the coated and non-coated probe.
We present the same results as earlier for the Epoxy-coated probe, that is a bar
graph representing the DC level for the received IR light before and after coating
on a ten second recording, see Figure 4.7. From the bar graph it can be seen that
the DC level is slightly lower then the DC level of the non-coated probe. Table 4.9
shows the mean value calculated for the DC and AC part of the signals presented
in Figure 4.7 where the AC part is calculated from seven consecutive maximas and
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Table 4.8: Table shows measurements done on a single subject fingertips. The
same probe was measured before and after coating of Parylene-C. mROS1 shows the
average of 7 maximas and minimas as calculated with equation (2.21). ∆ shows the
difference between the coated and un-coated probe.
Finger mROS1 mROS1 ∆
No- Parylene-C
Coating Coating
#1 1.07 0.94 0.13
#2 0.99 0.92 0.07
#3 0.96 1.03 -0.07
#4 1.02 1.11 -0.09
#5 0.97 0.98 -0.01
#6 1.01 1.06 -0.05
#7 0.99 0.92 0.07
#8 1.05 1.07 -0.02
#9 0.96 0.98 0.02
#10 1.00 1.05 0.09
Average 1.002 1.006 0.004
minimas. It can be seen from Table 4.9 that the amplitude of both DC and AC part
of the signal is lower after coating.
Table 4.9: The table shows amplitude recieved from the separated LEDs with the
probe prior to coating and after being coated with Parylene-C. The DC values are
calculated as average of 10sec recording and presented as mDC, the AC part is cal-
culated as the average amplitude between seven maxima and minima.
Measurement mDCIR mDCRED mACIR mACRED
[V] [V] [V] [V]
No-Coating 0.856 0.852 0.026 0.023
Parylene-Coating 0.629 0.624 0.017 0.017
Just as with the epoxy coated probe a graphical representation of the signals
acquired with probe nr.2 before and after coating are shown in Figure 4.8. It can
be seen graphically from the figure that the amplitude of DC and AC part of the
signal and noise level are similar for the non-coated and Parylene-C coated probe.
4.4 Measurement of the effect of cattle fat tissue
The reason for this test was simply to get a practical experience on how a fat tissue
effects the SpO2 signal that is acquired. The Parylene-C coated probe was used
for the measurements and a constant LED supply current of 1mA was used as in
previous test measurements. The fat tissue measurements were conducted with a
piece of cow fat acquired from local supermarket, see Figure 4.9. Layers from 0.5mm
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Figure 4.7: The bar chart shows the DC level of IR light measured with probe nr.2
before coating (No-Coating) and after coating (Parylene-Coating)
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to 4mm were sliced from the original piece and tested by placing them on top of the
probe and a finger on top of the fat layer as shown in Figure 4.10. It is not possible
to guarantee that the fat is uniform though it is assumed in these measurements.
The thickness of the fat is given in approximate value since it is quite elastic and
measuring the thickness accurately is hard. In Section 2.4.2 we presented data of
absorption coefficient for pig lard, that data gives us an estimate that light should
pass quite easily through the cow fat tissue.
The results from the measurements can be seen in Table 4.10, where the m
represents mean values that where calculated from six minima to maxima intervals
such as the one shown in Figure 3.15. The DC and mAC measurements represent
the amplitude and the values of mROS1 are calculated with equation (2.21) and σ
with equation (3.3). The ∆ represents the difference in ROS1 between measurements
with no fat tissue on top of the probe and measurements with fat tissue on top of
the probe.
The measurements from the ∼ 4mm were estimated from a single minima and
maxima since the signal strength reduced quite much and that explains why there
is no result presented for the mσ. It has been shown previously that by using a
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Figure 4.8: The figure shows the IR signal received from probe nr.2 before coat-
ing (No-Coating) and after coating (Parylene-C). The signals are presented as raw
data as well as after being filtered with a 4-point moving average filter presented in
equation (3.4).
Figure 4.9: The figure shows a piece of
cow fat acquired from local supermarket,
the piece is around one centimetre thick.
The scale of the image is in cm.
Figure 4.10: The figure shows one mil-
limetre thick layer of cow fat placed on top
of the probe, prior to measurements
moving average filter it is possible to reduce the noise in the signal significantly. An
example of this is Figure 4.11 where the whole piece of fat tissue shown in Figure
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Table 4.10: The table shows number of measurements as a function of fat tissue
thickness, the measurement included in the upper part of the table are the DCIR,
DCRED, mACIR and mACRED. The ROS1 is calculated from equation (2.21), the
mσ is calculated from equation (3.3) and ∆ shows the difference between the ROS1
for measurement with no-fat and fat tissue. All the measurement except the 4mm
thickness are measured from six maximas and minimas.
Measurement no-fat ∼ 0.5mm ∼ 1mm ∼ 2mm ∼ 3mm ∼ 4mm
DCIR [V] 0.6935 0.7080 0.6863 0.6678 0.6020 0.3420
DCRED [V] 0.6905 0.6997 0.6791 0.6612 0.5954 0.3380
mACIR[V ] 0.0196 0.0196 0.0131 0.0160 0.0129 0.0048
mACRED [V] 0.0190 0.0191 0.0125 0.0160 0.0134 0.0048
mROS1 0.9984 0.9750 1.0136 0.9623 1.0529 0.9906
σ 0.0526 0.1580 0.1494 0.0739 0.1718 N/A
∆ 0 -0.0234 0.0152 -0.03607 0.0545 -0.0078
4.9 is placed on top of the probe, the piece is around 1cm thick and has a thin layer
of meat on it as well as a tendon between the fat layer and the meat. The raw signal
in Figure 4.11 has obviously too much noise for anything to be distinguishable from
the raw signal, but after filtering with 8-point moving average filter, it is possible to
see the PPG signal.
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Figure 4.11: The figure shows a raw signal acquired by placing the piece of tissue
shown in Figure 4.9 on top of the probe and a finger on top of that. It is not possible
to distinguish the PPG signal from the raw data but when filtered with a 8-point
moving average filter the PPG signal becomes visible. The piece of tissue is not
uniform fat, it includes a piece of tendon and meat.
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Table 4.10 and Figure 4.12 show that the DC part of the signal drops as the
thickness of the fat layer increases. The change is quite small until the ∼ 4mm
layer is measured. The amplitude of the AC part of the signal changes much less
compared to the DC part. There is not a big difference in the mROS1 value between
tissues though there is some increase in the mσ meaning the noise level gets slightly
higher when increasing the thickness of fat. Figure 4.11 contradicts this since the DC
level is around 1.230, the reason for this is probably backscattering from the meat
or tendon increasing the DC part of the signal. This clearly shows how different
tissues reflect and absorb the light and how problematic it is to model it.
Figure 4.12: The bar graph shows the DC part of the IR and red LEDs as a function
of fat tissue thickness.
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5. DISCUSSION
In this chapter we will discuss the results presented in Chapter 4 as well as other
results that can be discussed from this thesis. Section 5.1 discusses the implemented
measurement system, how it performed and minor improvements/optimizations that
can be made to it. Section 5.2 discusses the test measurements that were performed,
such as temperature, coating and fat tissue measurements. Finally Section 5.3 dis-
cusses both the future impact of such a device as well as future developments and
major improvements that could be made on the current device.
5.1 Measurement system
Two measurement devices have been presented in this thesis, the first one previously
discussed as Oxmeter 1 and the improved version Oxmeter 2. Both measurement
systems where successful in giving a measurement of uncalibrated oxygen saturation,
though calibration of such a meter would be necessary before implantation. When
discussing the measurement system it is important to keep in mind that the purpose
of the system developed in this thesis is first and foremost to develop and justify a
device that is able to make measurements in vivo. For the external measurements
the ROS1 value calculated in most test measurements was quite constant correlating
to uncalibrated SpO2 values of around 75% which in accordance with the theory
since human SpO2 measurements under normal conditions don’t variate much from
the 96-99 %.
It was shown in Section 4.1 that both systems have quite high σ when measured
without any filtering, on average 8% for Oxmeter 1 and 9% for Oxmeter 2, this
difference can be partially explained by lower sampling rate and higher resolution of
Oxmeter 1 compared to Oxmeter 2 while Oxmeter 2 has higher LED supply current,
this explains why the difference is only around 1%. In this thesis the standard
deviation (σ) has been used as a measure of noise in the PPG signal acquired. More
interesting result was presented in Table 4.4 of Section 4.1 where a 4-point and
8-point moving average filter previously presented with equation (3.4) where used
to filter the separated IR and red PPG signals. This filtering lowered the standard
deviation of Oxmeter 2 measurements to 3.9% and 2.7%.
The AGC of Oxmeter 2 worked fine even though it drove the the LEDs supply
current to its highest possible value in all our measurements. This is explained by
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the reason that the integrator is grounded to 1/2 Vcc in the tests, meaning that
the DC output of the photosensor has to be higher then 1/2 Vcc. To test the AGC
the light in the room was turned on, it saturates the photosensor driving the DC
level output to become higher and thus the LEDs supply current controlled with
the AGC output voltage lowers. This can be optimized with setting the ground
voltage of the integrator or changing the gain of the integrator, if a non inverting
amplifier setup is used as an integrator a time constant is created that slows down
the response of the integrator. Thus a slower response to DC level changes occur,
which is a desired quality for the implantable meter. The reference voltage of the
ADC is also important when discussing the gain of the AGC versus the gain of the
output amplifier. When a meter would be implanted for test measurement, it would
be desirable to have higher interval for the LED supply current, since it was shown
in Figure 4.2 that higher supply current creates higher amplitude in signal.
The sampling frequency of Oxmeter 2 can be lowered significantly, since Oxmeter
1 utilized a sampling frequency of 250Hz and the amount of noise was not considered
significantly higher. A sampling frequency of around 30Hz should be sufficient to
get quality maxima and minima of the PPG signal. The filter response of the output
filter of the device should also be redesigned to get a sharper frequency response.
5.2 Interpretation of measurement result
5.2.1 Measurement of the thermal radiation of the probe
In Section 4.2 there are presented results from the temperature measurements of the
probe without coating for two LED drive currents, 1mA and 7mA. It is evident from
those measurements presented in Table 4.5, that the LEDs do not heat up with such
a low drive current. Since our system utilized at the highest a 2mA drive current, it
was not considered necessary to do further temperature testing on the coated probe
to ensure the FDA standard mentioned in Section 2.5.
A simple theoretical model predicting the temperature increase due to absorption
is presented, though it is just a rough estimate and it utilizes slightly higher values
for most parameters than the implantable device would have. From that theoretical
model presented with equations (4.1), (4.2) and (4.3) we are able to show that the
effect of LEDs temperature or radiation on the internal tissue will be very minimal
if any. The model does not account for any scattering inside the tissue which would
severely complicate the calculations and was considered out of the scope of the
thesis. This could be modelled with similar methods as scattering of lasers inside
tissue, presented in [26, 78].
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5.2.2 Measurement of the effect of coating on the probe
This is the most unique part of the test measurements in the thesis since no coating
studies have been conducted on SpO2 probes in literature. It is crucial for a working
implantable SpO2 meter to have a probe that is biocompatible and functioning
correctly in vivo. Tables 4.6 and 4.8 show that the difference in the ratio calculation
before and after coating of epoxy (probe nr.1) and parylene-C (probe nr.2) is very
small. Table 5.1 below summarizes this results, where the No-Coating difference is
simply the average mROS1 difference between probe nr.1 and nr.2 prior to coating.
This results indicates that coating of the probe with either epoxy or parylene-C has
minor effect on the ratio computation compared to the manufacturing difference
of the probes. This also shows clearly that each probe manufactured has to be
calibrated to get the most accurate result.
Table 5.1: The table shows comparison values from the coating tests were No-
Coating represents the difference between mROS1 for probe nr.1 and probe nr.2 prior
to coating. The epoxy and parylene-C are shown as difference in mROS1 before
coating and after coating of each probe.
Coating Type ∆ mROS1
No-Coating 0.021
Epoxy 0.002
Parylene-C 0.004
Table 5.2 presents comparison result for the amplitudes of Tables 4.7 and 4.9
where the difference between the non-coated probe and coated probe is presented.
This summarizes well the data presented in Figures 4.4 and 4.7 where the DC level
of the received IR wavelength was presented.
It is clear from this result that the DC level increases ≈ 1 V when the probe is
coated with epoxy. Even though the optical transmittance of EPO-TEK 301-2FL
medical grade epoxy is 99% as stated earlier in Section 2.5, the added thickness on
top of the photosensor and LEDs, increase the level of light that hits the sensor
without being absorbed by tissue. This is quite visible when the LEDs are turned
on the epoxy clearly colors up and radiates pass the POM barrier. This could be
studied further and tested with different epoxy thickness and probe designs, this
thesis is limited to a single probe and coating due to fabrication cost of each probe.
The Parylene-C coating on the other hand reduces the DC-level of ≈ 0.230 V,
this is lower than expected since previous studies with a layer of 20 µm showed
optical transmittance of 95 % as stated in Section 2.5. Studies measuring the effect
of Parylene-C coating on photosensors were not found in literature and could be
studied in more detail. The difference of amplitude in the AC part of the epoxy
coated probe was lower than for the Parylene-C coated one as presented in Table
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Table 5.2: The table shows a comparison result from Tables 4.7 and 4.9 where DC
and the average AC values of the amplitude is compared before and after coating of
epoxy and parylene-C.
Coating ∆ DCIR ∆ DCRED ∆ mACIR ∆ mACRED
Type [V] [V] [V] [V]
Epoxy +1.075 +1.077 -0.012 -0.011
Parylene-C -0.231 -0.228 -0.006 -0.006
5.2, where it is around 12mV compared to 6mV for the Parylene-C coated probe.
The AC amplitude of the Parylene-C coated probe complies pretty well with the
DC amplitud as presented in Table 4.7 where it is degraded around ≈ 73%.
5.2.3 Measurement of the effect of cattle fat tissue
The measurement of fat tissue effect was shown in Section 4.4, it was mainly done
to get some practical experience on how the light might propagate through the
fat tissue since there is no perfusion in the fat layer. Figure 2.17 in Section 2.4.2
had already shown that the absorption coefficient of pig fat is very low compared to
other tissue and water as shown in Figure 2.5 and in Table 2.2. In our measurements
layers from 0.5mm to 4mm where placed on top of the probe and the ROS1 measured
without any filtering. The result presented in Table 4.10 shows mainly two things,
the first is that the amplitude of the DC or AC part is not affected greatly until 4mm
thick layer of fat, Figure 4.12 shows this in an intuitive way that can be compared
to Figures 4.4 and 4.7. When the figures are compared it is clear that the coating
process has more constant effect while the effect of fat depends on how uniform
thickness it has.
Secondly the data in Table 4.10 shows that there is not much change in the average
ROS1 measurements as shown with ∆, but the mσ is slightly higher in most cases.
This indicates that noise increases in relationship with thickness of fat. It should
be emphasized that this test was quite unscientific and the effect of fat absorption
and scattering from this measurement should not be taken literally. The test still
indicated that SpO2 meter could function in an environment with some millimeters
of fat surrounding it. When filtered with a moving average filter as Figure 4.11
shows, the thickness of tissue can be up to one cm without having any perfusion, as
long as light will get in contact with well perfused tissue.
5.3 Future considerations
This thesis has focused on developing a device that could be used for prototype
measurements of implantable SpO2 signal. It has focused on problems that have
little or no publications instead of copying classic SpO2 meter approaches. This
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leaves room for many improvements that can be done on the device. This also
creates a foundation for a discussion on the future impact of an implantable SpO2
meter.
5.3.1 Future developments and improvements
There are many minor and major improvements that can be done on the current
system. Few of the minor ones listed in previous sections and chapters are to improve
the low-pass filter of the output amplifier, optimizing the AGC regulation, explore
more in depth the effect of coating on both LEDs as well as photosensors and to
develop further the fabrication method of the epoxy coating.
The major improvements are mostly related to the power consumption of the
device, this thesis focused mostly on the LEDs power consumption since literature
review reveled it as major part of the power consumption, see Section 2.7. In Oxme-
ter 2 the most power consuming component is the transimpedance amplifier OPA380
with a quiescent current ≈ 6.2mA at 3.3V Vcc. As stated previously in Section 2.7
Sarpeshkar et al. [31, 87] have designed an ultra-low power transimpedance amplifier
that has a logarithmic response thus amplifying the AC part of the signal much more
than the DC part. It has been stated previously several times that in implantable
SpO2 measurements there is a possibility of low perfused signal, Sarpeshkar tran-
simpedance amplifier would thus fit perfectly to our need.
Another major development is the pulsing of the LEDs, we utilize a simple square
wave from the MCU but more common in SpO2 measurements is to have switching
circuit that first lights the red LED then there is a timing interval during which
there is no light and then the IR LED is lighted on. This gives a measurement
of the ambient light that is effecting the meter, it can thus be removed from both
the red and IR PPG signals. This was considered unnecessary since it increases
the complexity of the circuit and ambient light measured in vivo is expected to be
minimal. Yet another improvement on the pulsing of the LEDs would be to utilize
PWM as stated previously in Section 2.6, then it is possible to reduce the duty
cycle of the LEDs supply current and thus reducing the overall current consumption
by turning the same LED on and off multiple times with a high frequency before
switching to the other LED.
The calibration of the meter is something that would have to be done to validate
the measurements. Calibrating an SpO2 meter is becoming a standard procedure
but quite expensive since it utilizes a CO-oximeter or intravenous meter and the oxy-
gen percentage of the subject has to be varied for full accuracy. As stated earlier in
Section 2.1.3, theoretical methods have failed to give an universal calibration equa-
tion. According to Moyle many research groups are currently working on calibration
methods that utilize human blood in artificial circulation [24].
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Further Signal Processing methods can as well be developed, both in analog and
digital domain. An optimizing point on how much work is there worth doing on the
MCU or DSP that is utilized in the final device. The algorithm presented in this
thesis is mainly for post processing in MATLAB, it would be possible to modify it
to run on a DSP but some kind of adaptive thresholding method would have to be
written for that. Another interesting processing point is the separation of red and
IR PPG signals and to even separate the DC and AC parts to acquire the highest
SNR by amplifying only the AC part. The moving average filter presented earlier
can be implemented easily on a MCU or a DSP once the separation of the PPG
signals have been done. These signal processing implementations have to be less
power consuming then recording the whole signal. Since the PPG signal is a quite
slow varying one, that might not be optimal.
The final development listed here is about the implantation procedure, we have
suggested placing the implant near the ribs of the cow in a similar position as
previous implants thus we are able to acquire backscatter as well as internal scatter
from tissue. This should be discussed with the veterinarians from previous implants
in the Remowel project.
Another interesting thing to develop would be to have some kind of porous bio-
polymer on each side of the implants surface that cells could grow in, thus keeping the
implant more still, since we know from literature and own experience that movement
of probe to tissue creates big motion artifacts as shown in Figure 2.13.
5.3.2 Future impact
There does not exist an implantable SpO2 meter on the market and papers previ-
ously published on the topic have focused on human measurements and applications.
Respiratory diseases and specially BRD are the most common family of diseases that
effect both feedlot- and dairy-cattle as stated previously in Section 2.4.1. Since ex-
ternal SpO2 measurements on cattle are time consuming, mostly because shaving is
needed and the thick skin and fur of the cattle it is not a standard procedure when
diagnosing respiratory problems. The diagnoses more commonly used are respira-
tory rate counted over one minute, breathing noise and body temperature of the
cow [67]. Those methods fail to detect diseases in their earliest stages and thus they
are easily transmitted between cattle. An implantable SpO2 meter could help in
those situations and a complete device measuring SpO2, respiratory rate and body
temperature would be ideal.
Those kind of application are mostly considered as a research tool for scientists
since implantations are still quite rare and expensive and not standardized procedure
in stables. In last years serious respiratory diseases have spread across the world
such as the H1N1 and H5N1 more commonly know as "swine flu" and "bird flu".
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They have spread in animals and humans, an implantable SpO2 meter could be used
in drug development studies for such diseases. This device could also be utilized for
other animals, we have stated previously in Section 2.3 that cattle move less than
other domesticated animals and is thus an ideal candidate to test such a device.
Another application is SpO2 meters that are already used externally for rats and
mice in toxicology and drug development studies, an implantable SpO2 meter could
be used in such measurements. A more futuristic approach would be incorporate
respiratory monitor in race horses that would measure both respiratory rate and
SpO2 for optimized training purposes. If the implantation procedure is simple and
cheap enough such as in the case of radio-frequency identification tags (RFID) tags
the possibilities are even greater, with the possibility of utilizing an implantable
SpO2 meter for monitoring purposes.
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6. CONCLUSION
This thesis presented a novel device for implantable SpO2 measurements, that can
help to diagnose respiratory diseases not only in dairy-cattle but as well other an-
imals. The benefit of this diagnosing method is mainly thought to help in the de-
tection of BRD which is the main cause of mortality and morbidity in both feedlot-
and dairy-cattle. It presents an application that can be used as a monitoring device
for outbreaks, for drug response monitoring and to be incorporated in the well-being
monitoring device previously developed at TUT for the Remowel project.
The thesis covers wide scope of topics related to the thesis title, where the main
focus was on developing a prototype device that could work in vivo. No implantable
commercial device exists that records SpO2 and only handful of publications exist
on the topic that cover mostly basic approach to SpO2 measurements. The first
approach was to solve a number of minor problems regarding the device design and
development, such as the circuit design and components selection, power consump-
tions of LEDs, AGC control of LEDs, noise filtering of the signal, and processing of
the data.
When the prototype device had been developed the author of this thesis decided
to focus more on topics where little or no publications had been done. Those topics
are related to the biocompatability of the probe which include coating of the probe
and thermal effect on tissue from the probe. Another topic is related to the effect
that fat tissue, surrounding the probe, will have on the signal acquisition.
Two types of coatings where conducted on a set of special probes designed and
manufactured for the thesis, the coating types included epoxy coating with medical
grade epoxy and Parylene-C coating. Both types of coatings differ in texture and
processing methods, where Parylene-C had a more complex processing method but
with lesser effect on the signal. The thesis points out an opportunity to research
the effect of coating on both LEDs as well as photosensors, since there is a lack of
publications focusing on this topic. The thermal effects of the probe on the tissue was
considered minimal from measurements and theoretical calculations. It is possible
to study the thermal effects in a greater aspect with an active field of human tissue
modelling existing. A practical test was conducted with cow fat acquired from local
supermarket. Although the test can not be taken literally it gives an estimation of
the effect that fat tissue has on SpO2 measurements where there is no perfusion.
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With some minor signal processing methods it was possible to acquire signal through
1cm thick tissue that had no perfusion.
Implantation is an expensive procedure and it is the author’s believe that the
main complications for implantable SpO2 measurements have been solved in this
thesis. The main output of the work starts with a novel prototype of a SpO2 meter
optimized for implants in both functionality and number of components used, and
it is followed by new research on coating and fat tissue effects, which is crucial
information prior to implantation. Analyses of the noise that would possibly affect
the signal were conducted from data of previous implants from the Remowel group.
Those analyses pointed out that the dairy-cow is an ideal candidate to test such a
device since it moves less and slower than other domesticated animals. It is thus
proposed that further development of the device would need some measurement data
from in vivo measurements, only then possible applications for other animals could
be developed.
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A. APPENDIX: MATLAB CODE
Code A.1: SpO2_algorithm.m
c l e a r a l l
%load the wanted s i g n a l
load signal_1 . mat
%clean up the s i gna l , manual d e c i t i o n o f which part o f the s i g n a l we want
%to process , 8 minimas−and−maximas p r e f e r r e d .
y = y (501 :2500) ;
x = x (501 :2500) ;
%Separat ion o f wavelengths , IR and RED are double v e c t o r s that show the
%l o c a l maxima and minima with i n d i c e s . You need to s e t the th r e sho ld manually
manual_threshold_1 = 0 . 0 0 1 ;
[ IR , RED ] = peakdet (y , manual_threshold_1 , x ) ;
%peak and va l l e y (max and min ) o f each wavelength , again you need to s e t the
%thre sho ld manually
manual_threshold_2 = 0 . 0 1 ;
[ maxIR , minIR ] = peakdet ( IR ( : , 2 ) , manual_threshold_2 , RED ( : , 1 ) ) ;
[ maxRED , minRED ] = peakdet ( RED ( : , 2 ) , manual_threshold_2 , RED ( : , 1 ) ) ;
%p a r t i a l r a t i o c a l c u l a t i o n f o r equat ions ( 2 . 1 6 ) and ( 2 . 1 7 )
f o r n = 1 : l ength ( maxIR )−1
R_IR (n , 1 ) = minIR (n , 2 ) /maxIR ( n+1 ,2) ; %( 2 . 1 6 )
R_IR_2 (n , 1 ) = maxIR ( n+1 ,2)−minIR (n , 2 ) ; %( 2 . 1 7 )
end
f o r n = 1 : l ength ( maxRED )−1
R_RED (n , 1 ) = minRED (n , 2 ) /maxRED ( n+1 ,2) ; %( 2 . 1 6 )
R_RED_2 (n , 1 ) = maxRED ( n+1 ,2)−minRED (n , 2 ) ; %( 2 . 1 7 )
end
%equat ion ( 2 . 1 6 )
ROS1 = log ( R_RED ) . / l og ( R_IR ) ;
%equat ion ( 2 . 1 3 )
SpO2_ROS1 = (0.81 −0 .20 .∗ ROS1 ) . / ( 0 . 7 3+0 . 09 .∗ ROS1 ) ;
%mean equat ion ( 2 . 1 3 ) (8 peaks−and−va l l e y )
mSpO2_ROS1 = mean( SpO2_ROS1 )
%standard dev i a t i on o f equat ion ( 2 . 1 3 )
std_ROS1 = std ( SpO2_ROS1 )
%DC ex t r a c t i on
DC_IR = mean( IR ( : , 2 ) ) ;
DC_RED = mean( RED ( : , 2 ) ) ;
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%ra t i o c a l c u l a t i o n accord ing to equat ion ( 2 . 1 7 )
ROS2 = ( R_RED_2 . / DC_RED ) . / ( R_IR_2 . / DC_RED ) ;
%equat ion ( 2 . 1 3 )
SpO2_ROS2 = (0.81 −0 .20 .∗ ROS2 ) . / ( 0 . 7 3+0 . 09 .∗ ROS2 ) ;
%mean es t imat ion ( 2 . 1 3 ) (8 peaks−and−va l l e y )
mSpO2_ROS2 = mean( SpO2_ROS2 )
%standard dev i a t i on o f equat ion ( 2 . 1 3 )
std_ROS2 = std ( SpO2_ROS2 )
Code A.2: peakdet.m
f unc t i on [ maxtab , mintab ]=peakdet (v , delta , x )
%PEAKDET Detect peaks in a vec to r
% [MAXTAB, MINTAB] = PEAKDET(V, DELTA) f i n d s the l o c a l
% maxima and minima (" peaks ") in the vec to r V.
% MAXTAB and MINTAB con s i s t s o f two columns . Column 1
% conta in s i n d i c e s in V, and column 2 the found va lue s .
%
% With [MAXTAB, MINTAB] = PEAKDET(V, DELTA, X) the i n d i c e s
% in MAXTAB and MINTAB are r ep laced with the cor respond ing
% X−va lue s .
%
% A point i s cons ide r ed a maximum peak i f i t has the maximal
% value , and was preceded ( to the l e f t ) by a value lower by
% DELTA.
% El i B i l l aue r , 3 . 4 . 0 5 ( Exp l i c i t l y not copyr ighted ) .
% This func t i on i s r e l e a s e d to the pub l i c domain ; Any use i s a l lowed .
maxtab = [ ] ;
mintab = [ ] ;
v = v ( : ) ; % Just in case t h i s wasn ' t a proper vec to r
i f narg in < 3
x = (1 : l ength ( v ) ) ' ;
e l s e
x = x ( : ) ;
i f l ength ( v )~= length ( x )
e r r o r ( ' Input ve c to r s v and x must have same length ' ) ;
end
end
i f ( l ength ( delta ( : ) ) )>1
e r r o r ( ' Input argument DELTA must be a s c a l a r ' ) ;
end
i f delta <= 0
e r r o r ( ' Input argument DELTA must be p o s i t i v e ' ) ;
end
mn = In f ; mx = −I n f ;
mnpos = NaN; mxpos = NaN;
lookformax = 1 ;
f o r i=1: l ength ( v )
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this = v ( i ) ;
i f this > mx , mx = this ; mxpos = x ( i ) ; end
i f this < mn , mn = this ; mnpos = x ( i ) ; end
i f lookformax
i f this < mx−delta
maxtab = [ maxtab ; mxpos mx ] ;
mn = this ; mnpos = x ( i ) ;
lookformax = 0 ;
end
e l s e
i f this > mn+delta
mintab = [ mintab ; mnpos mn ] ;
mx = this ; mxpos = x ( i ) ;
lookformax = 1 ;
end
end
end
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B. APPENDIX: SCHEMATICS OF THE DEVICE
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